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1 Introduction
Interactions between peptides and lipids play a crucial role in many processes of living
organisms, since they are involved in cell processes such as fusion or transport. One effi-
cient technique to analyze such interactions is the electron paramagnetic resonance (EPR)
spectroscopy, in particular double electron electron resonance (DEER) and pulsed electron
double resonance (PELDOR) experiments, which allow to investigate the conformation
and orientation of model peptides in artificial membranes, to gain a deeper insight into
the complex lipid-peptide interactions of natural systems.[1] In order to use this analytical
technique, the peptides need to be labeled with molecules bearing a paramagnetic nitrox-
ide radical. This is achieved either by direct incorporation of an amino acid spin label
into the peptide by solid phase peptide synthesis (SPPS) or by side-directed spin labeling
(SDSL), whereby the spin label is covalently attached to the side-chain of the peptide via
a linker.[2]
To improve the accuracy of distance and orientation measurements by EPR spectroscopy
the semi-rigid 4-(3,3,5,5-tetra-methyl-2,6-dioxo-4-oxylpiperazin-1-yl)-l-phenylglycine
(TOPP) spin label was designed and synthesized by Stoller et al., which was successfully
incorporated in the transmembrane model peptide WALP by SPPS.[3,4] Studies of the spin
labeled WALP peptides revealed the α-TOPP spin label to be suitable for investigations
of peptide-lipid systems and showed promising results in PELDOR experiments.[4]
Therefore, the investigation of more complex protein systems using the the semi-rigid
α-TOPP spin label is highly desirable. However, this would require a reliable method for
the direct incorporation of this spin label into large protein systems. Since an effective
SPPS is limitated to peptides consisting up to 100 amino acid residues, the synthesis
of larger peptides remains still challenging and requires additional techniques. One syn-
thetical approach to construct large and modified proteins is the ligation of two or more
protein fragments. Thereby, the native chemical ligation (NCL) is one of the most used
ligation types to construct complex protein systems, since the presence of at least one
internal cysteine residue in the target protein is crucial to apply this technique.[5,6]
For the purpose to construct complex and α-TOPP spin labeled peptides, the NCL is
considered to be a promising approach. The introduction of the α-TOPP spin label in
peptides constructed by NCL would enable to investigate large peptide systems by EPR
spectroscopy using the semi-rigid α-TOPP spin label. Thus, one goal of this work was to
synthesize an α-TOPP spin labeled peptide by NCL.
Apart from expanding the application field of the semi-rigid TOPP spin label, the main
focus of this work was concentrated on the design and synthesis of a new rigid spin label,
that not only fill the role as the carrier of a paramagnetic center, but is additionaly able
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to induce or stabilize a specific conformation in peptides. This additional property would
address a common issue of the incorporation of rigid spin labels into peptides, which is
the disturbance of the native local conformation. By introduction of the new spin label
the local conformation of the peptide could be controlled and predicted.
Therefore, the design of the new spin label is based on the approach to stabilize the
peptide conformation by direct incorporation of a rigid spin label by SPPS. Considering
the high abundance of different types of turn domains in complex protein systems[7], the
β-turn was chosen as the target conformation.
Hence, the design and synthesis of a new spin label, that comprises an enhanced rigidity
and is capable to induce or stabilize β-turn conformations by geometrical preorganization
was attempted in the course of this work.
2
2 Nitroxides and their Application as Spin Labels for EPR
Spectroscopy
The electron paramagnetic resonance (EPR) spectroscopy is an important technique to
study the environment of paramagnetic centers within biomolecules according to electron-
nuclear or electron-electron interactions. Thereby, the pulsed techniques, such as double
electron electron resonance (DEER) and pulsed electron double resonance (PELDOR),
were developed to detect dipolar interactions between spin pairs within the biomolecule,
which are dependent on the distance between the paramagnetic centers and orientation of
the spin labeled biomolecule in respect to the magnetic poles during the measurement.[8,9]
Therefore, these pulsed techniques allow to receive information about intramolecular dis-
tances in the range of 1.8 - 6 nm and orientation of the probe.[10] Hence, these are impor-
tant tools to study conformational changes of peptides or peptide-lipid interactions, since
membrane or cell embedded biomolecules can be analysed.[8,10]
Besides the pulsed EPR experiments, there are alternative analysis techniques, such as
X-ray diffraction or nuclear magnetic resonance (NMR) spectroscopy, which do not re-
quire modifications of the biomolecules but have a limited application range. While X-ray
diffraction requires the preparation of crystalline biomolecule samples in high quality[8],
which is very challenging for proteins, the NMR spectroscopy is restricted to biomolecules
with molecular weights up to 30KDa[11] and requires relatively high amount of the sample
for the measurement.[8] In comparison to these techniques, the pulsed EPR spectroscopy
has the advantage to be applicable to a wide range of biomolecules, that can be prepared
for the measurement by paramagnetic labeling. Additionally, due to high sensitivity, this
technique does not require large amounts of the spin labeled biomolecule, so that concen-
trations of labeled samples in micromolar range are sufficient.[12]
In order to introduce paramagnetic centers into the biomolecule, there are two approaches:
the direct incorporation of paramagnetic monomers during synthesis or the side-directed
spin labeling (SDSL), that is based on the attachement of paramagnetic centers to the
biomolecule.[13]
In the next sections of this chapter, the basics and properties of the nitroxides, their
incorporation into proteins and applications of selected spin labels will be presented.
2.1 Basics of Nitroxide Radicals
The commonly known organic radical species, such as carbon-centered radicals gener-
ated by homolytical cleavage of azo compounds like azobisisobutyronitrile (AIBN)[14], or
oxygen-centered radical species generated from peroxides[15], readily react with electron
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rich functionalities or recombine with further radical species. Thereby, the high reactivity
of radical species, such as generated from AIBN, is exploited to initiate radical polymer-
ization reactions.[14]
In comparison to these reactive radical species, the nitroxide radicals exhibit an enhanced
stability[16,17] and mostly remain unaffected in different environments and under a wide
range of conditions during organic synthesis.[18]
Therefore, the nitroxide have a wide scope of application, which ranges from co-oxidants[19],
mediators in polymerization reactions[20], anti-oxidants[21,22,23] catalysts[24,25] and organic
radical batteries[26] to spin labels[27] for EPR spectroscopy.
Due to their unique stability, the nitroxide radicals are the most widly used paramagnetic
labels for the analysis of peptides by pulsed EPR techniques.[27] The long shelf life of
this species is mainly attributed to the delocalization of the unpaired electron along the
N-O bond of the nitroxide and to the shielding effect of the four neighboured α-methyl
groups, that prevent combination and disproportionation of the free-radical species.[17,27,28]
Thereby, the introduction of substituents in the α-position to the nitroxyl moiety is essen-
tial for the stability of the free-radical because the absence of hydrogen atoms in α-position
prevents the formation of nitrones by disproportionation according to two possible path-
ways shown in figure 1.[28,29,30]
Figure 1: Proposed mechanisms for disproportionation of α-hydrogen substituted nitroxides. The mech-
anism by Ingold et al. is based on a direct H-atom abstraction, while the mechanism proposed
by Braslau et al. is based on single electron transfer.[29]
In the first proposed mechanism (Figure 1, A) of disproportionation by Ingold et al., a
nitrone and hydroxylamine are generated by abstraction of the H-atom in α-positon to
the nitroxyl moiety.[28,29]
The second mechanism, that was assumed by Braslau et al., is based on a two-step process
(Figure 1, B): In the first step, a head-to-tail nitroxide dimer is formed, that undergoes
single electron transfer (SET), which results in the formation of an oxoammonium ion and
a hydroxylamine ion species. In the second step, a proton is transferred from the oxoam-
monium ion to the hydroxylamine ion to form the hydroxylamine and the nitrone.[28,30]
Methyl substituents in α-position are the most frequently used substituents, whereby other
substituents, such as ethyl[31] or cyclohexyl[32] groups, were also utilized for the design of
new spin labels in order to improve the stability of the nitroxides against reduction.[33,34]
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Nevertheless, α-substituted nitroxide radicals may also undergo decomposition reactions
under certain conditions. In case of alkyl-substituted nitroxide radicals, the correspond-
ing oxoammonium ion, that might be formed under acidic conditions, can decompose at
higher temperatures, as it was shown in studies on the (2,2,6,6-tetramethylpiperidin-1-
yl)oxyl (TEMPO).[35] In addition to that, nitroxide radicals with bulky substituents in
α-position tend to decompose by fission of the C-N bond.[28]
Despite the susceptibility of α-hydrogen substituted nitroxyls to decompose, a recent
study on the design of new stable nitroxide spin labels shown the possibility to synthe-
size α-hydrogen substituted nitroxide spin labels, that exhibit a high stability against
disproportionation.[28] Thereby, the disproportionation could be kinetically hindered by
introduction of a co-planar substituent in the γ-position of the nitroxide skeleton, which
stabilizes the nitroxide radical sterically, as well as stereoelectronically, by interacting
with the H-atom in α-position.[28]
Considering the application of the nitroxide radical as spin label, there is one common
problem that arises during synthesis under reductive or strongly acidic conditions: the
tendency of the nitroxide to convert to hydroxylamine[37], which results in the lost of its
paramagnetic property. This is caused by the redox activity of the nitroxide, which results
in the formation of an oxoammonium ion species by oxidation or a hydroxylamine by acid
catalyzed reduction (Figure 2).[37]
Figure 2: Disproportionation of α,α-dimethyl substituted nitroxides. Reduction of the nitroxide results
in the formation of a hydroxylamine (left) and oxidation of the nitroxide leads to formation of
an oxoammonium ion (right).
Therefore, reactions that involve reducing agents like sodium borohydrate (NaBH4)[37] as
well as reactions under acidic conditions[36], can lead to the formation of the corresponding
hydroxylamine, which is often reversible.[37,39] Thus, the nitroxide radical can be recovered
oxidatively by peroxides, such as hydrogen peroxide (H2O2), copper(II)-ions/oxygen[38],
manganese dioxide (MnO2), sodium periodate (NaIO4) or under aerobic conditions by
oxygen as oxidant.[37]
The first spin labels based on functionalized piperidine, pyrroline or pyrollidine ring struc-
tures were prepared by Rozantsev et al. and are the lead structures of the most widly
used spin labels for peptides today.[18]
2.2 Stability of Nitroxides
The stability of the nitroxide unit is correlated to its oxidation potential and reversibility,
that are strongly dependent on the chemical structure of the spin label.[37] In general,
every structural parameter, that has an influence on the electron distribution along the
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N-O bond of the nitroxide, has an impact on the oxidation potential and thus, on the
stability of the nitroxide radical.[37]
Since different spin labels show a distinct stability and reversibility of the nitroxyl moiety,
studies were conducted to explore the influence of the ring size[40], the ring substituents[41]
and heteroatoms in the ring[42] on the reduction potential and therefore, the stability of
the nitroxide radical.
Considering the ring size, reduction potentials of various nitroxyls were examined in stud-
ies, that were based on the reduction rate of the corresponding nitroxyls by ascorbate.[40]
In figure 3 the reduction tendency of nitroxide radicals with different skeletons is shown.
Thereby, the pyrollidine and pyrroline derived spin labels are more stabile against reduc-
tion of the nitroxyl to the corresponding hydroxylamine than the six-membered piperidine
nitroxide.[37,40]
Figure 3: Tendency of nitroxide to reduction increasing from left to right. Five-membered rings (pyrro-
line, pyrrolidine) are generally more stable against reduction than six-membered nitroxide
(TEMPO) or heteroatom substituted nitroxides (oxazolidine).[37]
In addition to that, most of the nitroxide radicals are prone to oxidize to the correspond-
ing oxoammonium ion, whereby this process is reversible. It must be considered, that the
tendency for oxidation is not the reverse one for the reduction.[37]
The prone to reduction or oxidation is related to the ring structure of the nitroxide, which
has an influence on the geometry around the nitrogen atom.[37] The nitrogen atom of the
oxidized oxoammonium ion species has a trigonal-planar geometry and its formation is
therefore, favoured for nitroxides that can easily adopt this geometry.[37] For the formation
of hydroxylamine species, the nitrogen amine of the nitroxide is pyramidalized and the
reduction of nitroxides is therefore, dependent on the capability of the nitrogen atom to
adopt this geometry.[37]
Additionally, the substituents in α-position to the nitroxide nitrogen atom have an impact
on the redox potentials, whereby exchanging the methyl groups by the more sterically de-
manding ethyl or cyclohexyl groups in piperidine or imidazoline based nitroxides resulted
in lower reduction rates (Figure 4).[37]
Figure 4: Increasing stability of nitroxide with bulky substituents in α-position against reduction.[37]
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2.3 Spin Labeling Techniques for Proteins
EPR spectroscopy is a non-invasive and non-destructive technique that allows the anal-
ysis of the structure, conformational changes and interactions of biomolecules, such as
proteins or nucleic acids.[27] Therefore, the biomolecules need to be modified with a para-
magnetic unit, which can be attached covalently to the biomolecule as a spin label or by
non-covalent interactions as a spin probe.[27]
For EPR analysis of protein systems, the nitroxide spin labels are applied as paramag-
netic reporters, due to the unique stability of the nitroxide radical under a broad range
of conditions and the various structural motifs.[16,18] Thereby, the nitroxide spin labels
can be introduced at specific positions in proteins under different labeling conditions and
the EPR analysis of the nitroxide spin labeled probes can be performed in different en-
vironments without affecting the paramagnetic properties. However, one disadvantage of
using nitroxide spin labels is their relatively bulky structure, which might cause structural
perturbation of the protein and should be minimized to draw reliable conclusions from
the EPR measurements. Thus, a wide range of spin labels with different structural motifs
have been developed and tested for specific applications.
In order to introduce nitroxide spin labels into proteins, two main strategies are employed:
the SDSL, using canonical and noncanonical amino acids residues for bioconjugation with
nitroxide spin labels, and the direct incorporation of paramagnetic amino acids by SPPS
or by direct encoding.[13]
In the following sections these labeling strategies will be described in more detail using
examples of selected spin labels.
2.3.1 Side-Directed Spin Labeling of Proteins
The SDSL approach is one of the most frequently used labeling strategies for proteins,
because it allows to label selectively specific sites in proteins under a wide range of condi-
tions, including biological conditions. Thereby, the labeling of specific positions in proteins
is based on chemoselective reactions between the nitroxide spin label and the amino acid
residues, that can be naturally occuring, as for labeling of cysteine residues by MTSL,
or be introduced as noncanonical amino acids bearing modified side-chain functionalities,
that undergoe conjugation reactions with spin labels.[43,44]
In the following sections SDSL techniques that are based on the canonical cysteine residues
and noncanonical amino acid residues are presented.
2.3.1.1 Spin Labeling of Cysteine Residues
The thiol group of the cysteine side-chains is, due to its nucleophilicity and high abun-
dance in proteins, one of the most used target-sites for spin labeling.[43] The thiol group
reacts selectively and readily with spin labels bearing either a methanethiosulfonate group
(MTSL) to form a disulfide bond[45] (Figure 5, A), or with maleimide functionalized spin
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labels to form a thioether bond[46] (Figure 5, B).
Figure 5: Schematic representation of SDSL of a cysteine containing protein using MTSL spin label (A)
and maleimide spin label (B).
However, the disadvantage to utilize cysteine residues as labeling sites is, that they are
often responsable for natural conformations of proteins by the formation of disulfide
bridges between cysteine residues pairs and are thus, crucial for the biological activity
of proteins.[47] For protein systems without cysteine residues, cysteine mutations have to
be introduced at the desired positions to employ MTSL or maleimide spin labels. More-
over, if the cysteine residue is not introduced as a modification, the labeling will occur
at all cysteine residues, that are present in native proteins. Thus, there is no possibility
to choose specific cysteine residues to label, which requires to remove further unwanted
cysteine residues. In addition to that, the handling of free cysteine side-chains in proteins
is challenging due to their susceptibility to oxidation under aerobic conditions.[48]
2.3.1.2 Spin Labeling of Noncanonical Amino Acid Residues
To overcome the limitations of the cysteine labeling, spin labeling strategies utilizing
noncanonical amino acids as labeling sites were developed. These labeling strategies are
based on chemoselective reactions between the functionalized side-chain of the incorpo-
rated non-natural amino acid and the appropriate functionalized spin label.[43] Thereby,
these strategies are based on the principles of click reactions, which were defined as
chemoselective, biocompatible, fast and highly efficient.[49] Thus, the copper(I)-catalyzed
azide-alkyne cycloaddition (CuAAC)[50,51] and the copper-free click reaction, such as the
strain-promoted azide-alkyne cycloadditon (SPAAC)[52], are frequently used for spin la-
beling and are discussed in the following sections.
2.3.1.3 Spin Labeling by Click Reactions
The CuAAC is a suitable reaction to label proteins with incorporated noncanonical amino
acid residues bearing an azide or alkyne moiety, that readily reacts with alkyne or azide
groups of spin labels (Figure 6).[53]
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Figure 6: Schematic representation of a CuAAC reaction between an azide functionalized protein and
an alkyne functionalized spin label.
Thereby, the reaction is performed under reducing conditions and is catalyzed by copper(I)-
ions.[50] The noncanonical amino acids can be introduced to the protein either by SPPS
or by genetic encoding, whereby these amino acids are structurally based on tyrosine or
lysine.
For example, Kucher et al. achieved quantitative labeling of eGFP, that was modified by
exchanging the tyrosine residue in position 39 by either an azide or alkyne functionalized
amino acid residue.[54] Therefore, the CuAAC was performed using CuSO4, benzoic acid
and sodium ascorbate as reducing agent to generate the catalytic active copper(I)-ion
species in-situ, that promoted the reaction between the alkyne or azide modified protein
and the azide or alkyne functionalized spin labels respectively.[54]
However, this labeling method has some drawbacks: The labeling reaction is performed
under reducing conditions, which might result in the reduction of the nitroxide and there-
fore, in the loss of the paramagnetic property of the labeled protein.[39] Additionally,
considering applications in cells, the azide functionality is known to have a tendency to
undergo reduction[55] under the given conditions, which makes the labeling less effective.
Moreover, a major drawback of this labeling approach is the formation of a relatively
flexible linker[56] between the protein backbone and the spin label, which can cause inac-
curate distance measurements by DEER.
To avoid the side-reactions caused by the reducing conditions, the copper-free click reac-
tion SPAAC, that is performed under neutral conditions without the additon of reducing
agents, was tested for spin labeling.
Therefore, Kálai et al. designed a cyclooctyne functionalized pyrroline nitroxide spin
label, which was successfully conjugated to an azide modified T4 lysozym by SPAAC re-
action (Figure 7).[57] However, the performance of the relatively bulky spin label in EPR
measurements needs to be study.
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Figure 7: Schematic representation of a SPAAC reaction between an azide functionalized protein and a
cyclooctyne functionalized spin label.
2.3.2 Direct Incorporation of Spin Labeled Noncanonical Amino Acids
The most SDSL techniques require the introduction of noncanonical amino acids into the
protein and subsequent labeling, which leads to the formation of a relatively flexible linker
between the protein backbone and the spin label. Due to the flexible bound nitroxide unit,
accurate EPR measurements of the orientation of secondary structure motifs in proteins
or the alignment of membrane incorporated proteins are not possible.
Therefore, another labeling approach was developed that is based on the direct incor-
poration of rigid spin labeled amino acids by SPPS. In the next two sections the di-
rect incorporation of spin labels with enhanced rigidity by SPPS will be presented using
the examples of the rigid 2,2,6,6-tetramethylpiperidine-N -oxyl-4-amino-4-carboxylic acid
(TOAC) spin label and the semi-rigid 4-(3,3,5,5-tetra-methyl-2,6-dioxo-4-oxylpiperazin-1-
yl)-l-phenylglycine (TOPP) spin label (Figure 8). In the third section the direct incorpo-
ration of an spin labeled lysine derivative SLK-1 (Figure 8) by genetic encoding will be
presented, which enables in vivo spin labeling.
Figure 8: Amino acid derived spin labels TOAC (left) and TOPP (middle) for direct incorporation into
peptides by SPPS and the SLK-1 spin label (right) for incorporation by genetic encoding.
2.3.2.1 Direct Incorporation of the TOAC Spin Label
The TOAC spin label was developed by Marchetto et al. as a spin labeled amino acid
derivative for the incorporation into peptides by SPPS.[58] Thereby, the amino group of the
TOAC spin label was protected by Fmoc to test the solid-supported peptide synthesis[59,60]
according to the Fmoc/tBu strategy[61,62], which allowed the introduction of the TOAC
spin label at any position of the peptide.[58]
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The TOAC spin label is derived from a α,α-disubstituted glycine and is a highly rigid
spin label, which was confirmed by conformational analysis of TOAC residues within short
peptides using X-ray diffraction.[63] The high rigidity is caused by the direct incorporation
of the spin label into the peptide backbone, whereby its motion is restricted to the con-
formational flipping of the six-membered piperidine ring. Furthermore, the X-ray studies
revealed the capability of the TOAC residue to induce or stabilize β-bends and 310-helical
conformations in double labeled peptides.[63,64]
Thus, the TOAC spin label was a promising candidate for the studies of peptide confor-
mation and alignment of membrane incorporated peptides by EPR spectroscopy, because
of its high rigidity and ability to stabilize helical or bent structures. However, one draw-
back of this spin label is its low stability under the final cleavage conditions using high
percentage of TFA in the cleavage cocktail, as usually applied in the Fmoc/tBu strategy
for SPPS.[58] In addition to that, it is known that the rigid TOAC residue can desturb
the local conformation[64] of the peptide, which results in an incorrect interpretation of
EPR experiments addressing the analysis of peptide structure or structural dynamics.
2.3.2.2 Direct Incorporation of the TOPP Spin Label
To overcome the drawbacks of already described rigid spin labels, such as the TOAC spin
label, Stoller et al. introduced the semi-rigid, chiral nitroxide amino acid 4-(3,3,5,5-tetra-
methyl-2,6-dioxo-4-oxylpiperazin-1-yl)-l-phenylglycine (TOPP), that was suitable for di-
rect incorporation into peptides by SPPS following standard Fmoc/tBu-strategy.[3] In
contrast to the rigid TOAC spin label, the TOPP spin label did not affect the peptide
conformation, which allowed its application in conformational studies of peptides. In
addition to that, the design of the TOPP spin label was based on the alignment of the
nitroxide N-O with the Cα-Cβ bond of the amino acid residue, which led to a defined
location of the nitroxide unit, even in the case of rotation about the Cα-Cβ or the C-N
bond.[3] Thus, the local assignment of the nitroxide unit simplyfied the interpretation of
data obtained from distance measurements.
Due to its high performance in distance measurements, the TOPP spin label was applied
for distance measurements of the WALP24 model peptide using the PELDOR/DEER
technique.[4] Therefore, distances within the TOPP double labeled transmembrane pep-
tide and the MTSSL double labeled analogue were measured in solution and in lipids to
compare the perfomance of both spin labels. Thereby, the distance measurements of the
TOPP spin labeled peptide were more accurate than of the MTSL labeled analogue.[4]
Moreover, the distances obtained for the TOPP spin labeled peptide did not change upon
incorporation into lipids, while the distances of MTSL spin labeled peptide varied in dif-
ferent lipid environment.[4] Hence, the TOPP spin label was considering to be a promising
canditate for structural studies of membrane incorporated peptides.
These results led to the development of the β-analogue of the TOPP spin label, which
was applied in studies of lipid incorporated transmembrane β-peptides, that adopt stable
11
helical conformations and serve as structural mimetics.[65] The results obtained from EPR
measurement revealed the high potential of the β-TOPP spin label for the application
in transmembrane β-peptides.[65] The PELDOR studies of β-TOPP spin labeled WALP
β-peptides, that were integrated into artificial membranes, allowed a detailed analysis of
the WALP peptide and supported the assumption of a 314-helix type conformation, that
was in accordance with the results obtained by circular dichroism (CD) analysis.[65]
2.3.2.3 Spin Labeling by Direct Encoding
The direct encoding starategy of noncanonical nitroxide amino acids allows to label ex-
pressed proteins by translation, which in turn enables to perform nitroxide labeling in
cells and therefore, give a rise to new application fields of EPR experiments.
In the study of Schmidt et al., the nitroxide amino acid SLK-1, which is derived from the
amino acid lysine, was successfully introduced by co-translation using a tRNAPyl/PylRS-
SL1 pair to thioredoxin (TRX) in living E. coli cells.[66] Subsequently, the genetically
encoded and SLK-1 labeled TRX was compared in further studies to a MTSL labeled
TRX mutant to evaluate the applicability of the SLK-1 spin label in distance measure-
ments using the DEER technique. Since the results obtained for the SLK-1 labeled TRX
were in a good agreement with the MTSL labeled TRX mutant, the SLK-1 spin is as-
sumed to be a very promising spin label for in-cell DEER experiments.[66] However, the
SLK-1 spin label exhibit a moderate stability during the protein expression and purifi-
cation steps. This was indicated by an integrity degree of 50 to 70%, which defines the
content of intact paramagnetic SLK-1 in the protein.[66]
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3 Synthesis of a New, Rigid and Conformation Stabilizing
Spin Label
The main goal of this work was the design and synthesis of a new rigid spin label, that
is able to induce or stabilize a β-turn conformation in peptides. By the current stage of
knowledge, there are not many rigid spin labels, that can stabilize or induce the local
conformation of peptides. One example is the 2,2,6,6-tetramethylpiperidine-N-oxyl-4-
amino-4-carboxylic acid (TOAC) spin label, which represents an α,α-disubstituted amino
acid and therefore, is helicogenic.[67]
However, the TOAC spin label is prone to reduction under acidic conditions, which makes
its use in SPPS challenging and its application limited.[68] Therefore, there is a high de-
mand for new rigid spin labels, that are stable under the SPPS conditions.
One challenge in the design of highly constrained spin labels is to avoid conformational
disruption by their incorporation into the peptide backbone. This issue can be addressed
by creating rigid spin labels that stabilize or induce a specific conformation.
Thus, in the course of this project the design of a new rigid spin label was based on
structural frameworks, that mimic the conformation of a β-turn by geometrical preorga-
nization.
There are several approaches to induce turn structures in peptides, such as macrocycli-
sation (A), N-methylation (B) or the usage of structural mimetics (D) or turn inducing
amino acids (C) (Figure 9).[69] However, considering the aim to use the new spin label for
investigation of natural proteins, the application of turn inducing amino acids is the most
advantageous approach, since they would closely resemble the native peptide residues.
Figure 9: Schematic overview of turn stabilizing approaches. Modified according to Pelay-Gimeno et
al.[69]
For the design of the new β-turn stabilizing spin label, the structure of the β-turn stabi-
lizing dipeptide developed by Sato et al. was adopted (Figure 10).[70] Moreover, to ensure
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high stability of the nitroxide radical under SPPS conditions and high rigidity, a pyrro-
line based nitroxide radical moiety was annealed to the five-membered ring of the bicyclic
skeleton.
Figure 10: Design of the new β-turn stabilizing spin label derived from the constrained dipeptide by
Sato et al.[70] H-bond between the ith and the 3+ith amino acid as crucial factor for β-turn
formation (left).[69] Structure of the new spin label derived from the azabicyclo amino acid[70]
by annealing the pyrroline spin label to the five-membered ring of the lead structure (right).
Thereby, the sulfur atom in the original dipeptide was exchanged by a carbon atom
in order to facilitate the synthetic design of the new spin label. By this simplification
the synthesis of the new β-turn inducing spin label could be adopted to the previously
described synthesis of an azabicyclic amino acid by Hénichart et al. starting from a γ-
lactam.[71] Thus, the synthesis of the new spin label is modified according to the published
procedure and is shown in figure 11. In the next sections of this chapter the development
of a strategy towards the synthesis of the new designed spin label will be described and
discussed.
Figure 11: Attempted synthesis of the new β-turn stabilizing spin label based on the protocol for the
synthesis of azabicyclo amino acid by Hénichart et al.[71]
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3.1 First Approach: Synthesis Starting from Carboxy Substituted
γ-Lactam Spin Label
In order to obtain the enantiomerically pure target spin label, it was aimed to adopt the
original synthetic route of the azabicyclo amino acid by Hénichart et al. for the synthesis
of the new spin label.[71] Since the original synthesis started from a carboxy substituted γ-
lactam, the preparation of the corresponding γ-lactam spin label was required. Therefore,
a synthetic route that is illustrated in figure 12 was developed.
Figure 12: Schematic representation of the synthesis of the new β-turn stabilizing spin label.
The synthesis of the γ-lactam spin label started from an unsaturated dibromide spin label,
that could be prepared in nine steps from the commercial available cyclic amine according
to previously published procedures.[72,73,74] In the next step the dibromide undergoes a
double alkylation with benzyl amine and is subsequently oxidized in α-position to yield
an imide spin label. Then, the imide spin label is transferred into the nitrile spin label
by reductive cyanation and is finally hydrolyzed to form the desired carboxy substituted
γ-lactam.
In the following sections of this chapter the preparation of the dibromide spin label and
the carboxy substituted γ-lactam spin label is described.
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3.1.1 Synthesis of the Dibromide Spin Label
The first step of this project was the synthesis of the dibromide spin label following pre-
viously described protocols.[72,73,74]
Starting from the commercial available piperidone 1, a dibromo ketone 2 was synthesized
by bromination of the cyclic ketone in α-position (Figure 13).[72] Therefore, a solution of
bromine in glacial acetic acid (HOAc) was added at 0 ◦C to the cyclic ketone 1 dissolved
in glacial HOAc and the reaction was stirred at room temperature for 18 h. The dibromo
ketone 2 was isolated in a good yield and used in the next step without further purification.
Figure 13: Synthesis of the Michael product 5 from commercially available 2,2,6,6-tetramethylpiperidin-
4-one 1.
In the next step the hydrobromine salt 2 was converted by a Favorskii type reaction into
the vinyl methyl ester 3 using sodium methoxide (NaOMe) as nucleophilic agent.[72] For
the synthesis, the dibromide ketone 2 was dissolved at 0 ◦C in MeOH and treated with a
methanolic 2M NaOMe solution. The reaction was stirred at 0 ◦C for 2 h and the crude
product was purified by column chromatography to yield the unsaturated methyl ester 3
in a good yield.
Then, the unsaturated methyl ester 3 was oxidized by meta-chloroperbenzoic acid (m-
CPBA) in dichlormethane (DCM) at 0 ◦C for 2 h to yield the paramagnetic methyl ester
spin label 4.[72] The nitroxyl spin label 4 was purified by column chromatography and
obtained in a good yield. The synthesis was continued with a Michael addition between
the vinyl methyl ester 4 and nitromethane (MeNO2).[74] Therefore, MeNO2 was added
to a solution of the vinyl methyl ester 4 and the base diazabicycloundecene (DBU) in
acetonitrile (MeCN) and the reaction was stirred for 24 h at 50 ◦C. The desired Michael
product 5 was obtained in a good yield by column chromatography.
With the Michael product 5 in hands, the synthesis of the dibromide spin label 10 was
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started (Figure 14).[73] Starting by a Nef reaction, the nitroalkane moiety of the Michael
product 5 was converted into an aldehyde 6 by hydrolysis of the nitronate salt interme-
diate under oxidative conditions. First, the Michael product 5 was dissolved in MeOH
and reacted upon addition of KOH at 0 ◦C to the nitronate salt intermediate. After
stirring for 1.5 h a solution of potassium permanganate (KMnO4) and manganese sulfate
(MgSO4) in water was added and the reaction was stirred at 0 ◦C for additional 2 h. The
crude aldehyde 6 was purified by column chromatography and isolated in a moderate yield.
Figure 14: Synthesis of the dibromide spin label 10 from the Michael product 5.
In the next steps, the aldehyde and the methyl ester group of the spin label 6 were
reduced to primary alcohol groups, that were converted into iodide alkanes by nucleophilic
substitution via the corresponding methanesulfonates intermediates.
To obtain the reduced spin label 7, NaBH4 was added to a solution of the spin label
6 in MeOH at 0 ◦C and the reaction was stirred at room temperature for 45min. After
purification by column chromatography the dihydroxyl spin label 7 was isolated in a good
yield.
Afterwards, the dihydroxyl spin label 7 was converted into the diiodide spin label 8
in a two-step process. Therefore, the hydroxyl groups of spin label 7 were converted
to good leaving groups by adding methanesulfonyl chloride (MsCl) to a solution of the
dihydroxyl spin label 7 and the base triethyl amine (Et3N) in DCM at 0 ◦C. The crude
dimethanesulfonate was formed after 1 h at room temperature and was used in the next
step without further purification. Next, the crude dimethanesulfonate and sodium iodide
(NaI) were dissolved in MeCN and the reaction was stirred at 75 ◦C for 34 h. After the
purification by column chromatography the diiodide 8 was obtained in a good yield.
In order to synthesize the unsaturated dibromide spin label 10 the diiodide spin label 8
was applied in a base mediated elimination to yield the diene spin label 9. The latter was
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converted into the unsaturated dibromide 10 by electrophilic addition in three steps.
For the elimination reaction the diiodide spin label 8 was dissolved in ethanol (EtOH) and
stirred at 80 ◦C upon the addition of 10% aqueous sodium hydroxide (NaOH) solution for
40min. After purification by column chromatography the diene spin label 9 was isolated
in a good yield.
Before performing the electrophilic addition, the nitroxide radical unit was converted to
its hydrochloric salt in order to prevent nitroxide radical mediated side-reactions with the
bromine. Therefore, the diene spin label 9 was heated for 1 h at 80 ◦C in a 2.4M solution
of hydrogen chloride in methanol to yield the hydrochloric salt after evaporation of the
solvent.
The hydrochloric salt was dissolved in chloroform and stirred upon the addition of bromine
for 30min at 65 ◦C to yield the crude dibromide salt.
To recover the nitroxide radical, the hydrochloric salt was oxidized by sodium nitrite
(NaNO2) in water for 20min. Finally, purification by column chromatography yield the
desired spin label 10.
3.1.2 Synthesis Starting from Carboxy Substituted γ-Lactam Spin Label
After the successful preparation of the unsaturated dibromide spin label 10, the imide
spin label 12 was prepared from a cyclic amine 11 by iodine mediated oxidation (Fig-
ure 15).
Figure 15: Synthesis of the imide spin label 12 from the dibromide spin label 10.
Therefore, nucleophilic substitution of the unsaturated dibromide spin label 10 with ben-
zyl amine (BnNH2) and K2CO3 as a base in MeCN was performed at 80 ◦C for 20 h. After
purification by column chromatography, the cyclic amine 11 was obtained in a moderate
yield.
For the oxidation to the imide 12, the secondary amine 11 was stirred with iodine and
NaHCO3 in a mixture of THF/H2O at room temperature for 14 h. The imide 12 was
obtained in a moderate yield after purification by column chromatography.
Finally, the reductive cyanation[75] of the imide spin label 12, followed by acidic hy-
drolysis, should result in the formation of the carboxyl substituted γ-lactam spin label
14 (Figure 16). Therefore, a 1M solution of DIBAL-H in hexane was added to the imide
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Figure 16: Attempted reductive cyanation of the imide 12 and subsequent hydrolysis to form the carboxy
γ-lactam spin label 14.
spin label 12 in THF at −40 ◦C. The reaction mixture was allowed to warm up to −15 ◦C
and was stirred at this temperature for 2 h. Then, potassium cyanide (KCN) was added
to the crude intermediate at −15 ◦C and the reaction was continued for 1.5 h.
However, the reductive cyanation reaction failed and no formation of the desired product
13 could be detected by ESI-MS analysis of the crude reaction mixture. A possibile reason
for the failure could be the decomposition of the spin label 12 under the relatively harsh
reductive conditions, because the analysis of the crude reaction mixture by TLC revealed
the formation of multiple side-products.
Since the reductive cyanation is crucial for the synthetic route and the reaction requires
the usage of DIBAL-H as reducing agent, which was probably responsable for the de-
composition of the imide spin label 12, possible approaches were considered to mask the
nitroxide unit.
Therefore, the usage of a nitroxide protecting group was taken into account. In general,
two different classes of protection groups for nitroxides were considered: the methoxy
protection group and the 2-nitrobenzyl derived group. However, these protecting groups
are not compatible with the spin label at this stage.
Protection of the nitroxide by the methoxy would require oxidative removal of these
groups, using hydrogen peroxide. Thus, performing the nitroxide deprotection in the
next step of the reaction sequence could lead to side reactions with the double bond or
result in cleavage of the lactam bond. On the other hand, utilizing a 2-nitrobenzyl group
could lead to reduction of the carbonyl groups, because the protecting group is installed
in a two-step process, whereby the nitroxide needs to be reduced hydrogenolytically to
the corresponding hydroxylamine in the first step. Thus, at this stage of the synthesis,
there was no possibility to modify the synthetic route in order to continue the synthesis
from the imide12 and a new synthesis approach for the desired γ-lactam was required.
Generally, there is one other possible route for the synthesis of the desired γ-lactam
derivative, which seems to be simpler in terms of synthetical effort at first glance. This
retrosynthetical approach is presented in figure 17, whereby the retrosynthetical cut is set
on the amide bond, so that the desired γ-lactam is synthesized by a condensation reaction
between a carboxyl and the amine group of an amino acid moiety.
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Figure 17: Retrosynthetic design of the β-turn stabilizing spin label. The key step of the synthesis is the
formation of an carboxy γ-lactam spin label via a condensation reaction between the carboxyl
and the amine group of the pyrroline substituents.
However, this approach has a big disadvantage, because it requires the installation of
an amino acid substituent and an carboxyl substituent that are either oriented in one
direction or are in one plane with the double bond of the pyrroline nitroxide. Thereby,
the formation of an appropriate enantiomer in case of a pyrrolidine nitroxide, or the cis-
isomer in case of a pyrroline nitroxide, is crucial for the formation of the annealed lactam,
because the ring substituents need to come in close proximity to undergo the condensation
reaction.
Considering the synthesis of the cis-isomer, one main challenge needs to be considered:
the introduction of the relatively complex and bulky amino acid residue directly on the
double bond in cis-position to the carboxyl substituent. One the one hand, it is very
challenging to install an amino acid moiety in few steps and on the other hand, the streri-
cal demand of the amino acid residue might be too big to be installed on the relatively
bulky pyrroline nitroxide with four methyl substituents in α-position to the nitroxide.
If the installation fails due to sterical reasons, a step-wise formation of the amino acid
substituent could also fail.
Apart from the sterical demand of the amino acid substituent, this intermediate shows
another synthetical challenge, which is difficult to accomplish: the installation of the sub-
stituents in cis-position. This requirement is not easy to realize, due to the size of the
substituents, which would rather force the substituents in trans-position.
Therefore, the overall synthesis route might become even more complex than the previous
one, starting from a dibromine, because an appropriate synthetic strategy for the prepara-
tion of the cis-isomer is highly restricted by the sterical demand of the bulky substituents.
Taking all these considerations into account, synthesis of the azabiciclo amino acid derived
spin label is dependent on the sterical compatibility in each step of the synthesis.
Therefore, a completely new synthetic approach was developed that was not based on
the preparation of a substituted γ-lactam and is presented in the next section of this
chapter.
3.2 Second Approach: Synthesis via Anionic Cyclisation Reaction
The previous approach to synthesize the β-turn inducing spin label via a carboxy sub-
stituted γ-lactam spin label 14 was not continued due to the unsuccessful preparation of
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the latter. In addition to that, the overall synthesis of the target spin label would require
22 reaction steps, which makes the preparation very elaborate and time consuming.
Therefore, a new approach for the synthesis of the β-turn inducing spin label was devel-
oped, that is shown in figure 18.
Thereby, the key step of the new synthesis route is an intramolecular anionic cyclisation
between a vinyl bromide and the carbonyl of an imide. The developed approach required
the synthesis of a suitable vinyl bromide spin label, which was prepared using previously
published procedures.[76,15]
Figure 18: Retrosynthetic design of the β-turn stabilizing spin label. The key step of the synthesis is an
intramolecular anionic cyclisation of an imide substituted spin label, that is synthesized from
a vinyl bromide spin label. The substituent x represents a suitable carboxyl precursor.
First, the anionic cyclisation reaction was tested using a less complex imide spin label, that
could be prepared in a few steps. In case of a successfull cyclisation reaction, the synthetic
route would be redesigned in terms of a suitable substituted spin label intermediate for
the synthesis of the β-turn inducing spin label.
3.2.1 Testing the Anionic Cyclisation Reaction for the Synthesis of the Azabicyclo
Spin Label
Figure 19: Schematic representation of testing the anionic cyclisation reaction for the synthesis of the β-
turn inducing spin label. The reactant for the anionic cyclisation is prepared from previously
synthesized vinyl bromide and imide by nucleophilic substitution.
To test the new approach for the synthesis of the β-turn inducing spin label precursor
(Figure 19), a bromide spin label 18 was prepared from the commercially available cyclic
ketone 15 (Figure 20), which was applied in a Favorskii reaction using sodium hypo-
bromite (NaOBr) to form the ring contracted spin label 16.[76]
Therefore, the cyclic ketone 15 was dissolved in a mixture of 1,4-dioxane/water and added
at −5 ◦C to a solution of in-situ generated NaOBr in water. The reaction was stirred at
−5 ◦C for 30min and the formed vinyl bromide 16 was isolated by filtration. Due to for-
mation of several side-products, such as a vinylic dibromide and saturated compounds,[76]
the yield of the spin label 16 was low.
In the next step, the carboxyl group was converted into a primary alcohol in a two-step
21
synthesis to reduce the carboxylic group without affecting the double bond of the spin
label 17. Thereby, the carboxyl group was converted by ethyl chloroformate (ClCO2Et)
into the corresponding carboxylic anhydride intermediate, that was reduced by sodium
borohydride (NaBH4) to the primary alcohol 17.[77]
Figure 20: Synthesis of the vinyl bromide spin label 18 starting from the commercially available 4-oxo-
TEMPO 15.
For the synthesis of the carboxylic anhydride intermediate, the carboxylic acid 16 was
dissolved in diethyl ether (Et2O) and stirred upon the addition of ethyl chloroformate and
the base Et3N at 0 ◦C for 2 h. Afterwards, the crude intermediate was used immediately
without further purification in the next step. Therefore, the crude anhydride intermediate
and NaBH4 were reacted in THF/MeOH for 1 h at 0 ◦C. The primary alcohol 17 was
isolated by column chromatography in a good yield.
Then, the bromide 18 was formed by nucleophilic substitution of a methanesulfonate
intermediate, that was previously prepared from the primary alcohol 17, with lithium
bromide (LiBr).[77] In the first step, the methanesulfonate intermediate was formed by the
reaction of the alcohol 17 and MsCl upon addition of the base Et3N in dichlormethane
(DCM) at 0 ◦C for 2 h. Then, the crude methansulfonate intermediate and LiBr were
stirred in acetone at 80 ◦C for 1 h to form the bromide spin label 18, that was isolated by
column chromatography in a moderate yield.
To perform the intramolecular anionic cyclisation, an functionalized cyclic imide 20 was
attached to the spin label 18 by nucleophilic substitution. Therefore, the imide 20 was
prepared following a previously described procedure (Figure 21).[78]
Figure 21: Preparation of the cyclic imide 20 from commercially available Boc-L-glutamine 19.
The Boc-L-glutamine (Boc-Gln-OH) 19 was activated by 1,1’-carbonyldiimidazole (CDI)
upon the addition of a catalytic amount of 4-(dimethylamino)pyridine (DMAP) in THF
and was subsequently heated at 70 ◦C for 18 h to form the cyclic imide 20. The cyclic
imide 20 was purified using column chromatography and could be obtained in a good
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yield.
Then, the synthesis of the β-turn inducing spin label was continued by a nucleophilic
substitution of the bromide spin label 18 to prepare the imide functionalized spin label
21 (Figure 22). Therefore, the bromide spin label 18, the imide 20 and the base potassium
carbonate (K2CO3) were reacted in DMF at 90 ◦C for 2 h. After aqueous work-up, the
formed imide 21 was used in the next step without further purification, because attempts
to find a suitable condition for chromatographical separation of the imide 21 from a by-
product with a similar polarity failed. Thus, the crude imide 21 was applied in the anionic
cyclisation reaction to form the basic framework of the desired β-turn inducing spin label.
Figure 22: Synthesis of the azabicyclo spin label precursor 22 to test the anionic cyclisation reaction.
The anionic cyclisation is an intramolecular reaction, that leads to the formation of cyclic
products from carbonyls bearing either aryl or vinyl halides. During the reaction, a stan-
nyl anion is produced in-situ from Bu3SnSiMe3, which reacts with the aryl or vinyl halide
to form the corresponding aryl or vinyl anion. The generated aryl or vinyl anion readily
attacks the carbonyl group to form a cyclic product. In some cases, the cyclic product
can subsequently eliminate water to yield the unsaturated cyclic product.[80,81]
To test the anionic cyclisation for the formation of the framework of the β-turn inducing
spin label 22, the crude imide spin label 21 was added at 0 ◦C to a solution of Bu3SnSiMe3
and CsF in DMF. The reaction was allowed to stirr a room temperature for 21 h and the
cyclic product 22 could be isolated by chromatographic purification in a moderate yield
over two steps from the bromide spin label 18. Due to the successful construction of the
spin label framework 22, the reaction should be performed with a suitable substituted
imide to incorporate the missing carboxyl functionality to the spin label 22.
23
3.2.2 Synthesis of the Azabicyclo Spin Label by the Anionic Cyclisation Using
Different Reactants
In order to introduce a carboxyl group, different C-C bond formation strategies for the
preparation of a carboxy functionalized reactant for the anionic cyclisation were considered
and are summerized in figure 23.
Figure 23: Attempted synthetic strategies for C-C bond formation. Routes A and B aim to introduce
a nitrile group as carboxyl acid precursor via Strecker or a cyanohydrin reaction. Route C
is based on the direct nucleophilic addition of the cyclic imide to the carbonyl C to form a
secondary alcohol.
Thereby, the synthesis of the functionalized reactants started from the aldehyde 23, whose
synthesis was previoulsy described.[81]
The aldyhede 23 was synthesized from the previously described primary alcohol 17 by
oxidation (Figure 24).[82] Therefore, the primary alcohol 17 was stirred with manganese
dioxide (MnO2) in chloroform for 4 h at 70 ◦C. The aldehyde spin label 17 was purified
by column chromatography and isolated in a good yield.
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Figure 24: Synthesis of the aldehyde 23 from the previously described alcohol 17 by oxidation.
It has to be noted, that the reactions described in the following sections of this chapter
are not enantioselective and would lead to formation of different diastereomers of the tar-
get spin label. This would require the separation of these diastereomers by reverse-phase
high performance liquid chromatography (RP-HPLC). However, the overall aim of this
project was to establish a synthesis of the β-turn inducing spin label for incorporation
into model peptides, in order to evaluate its ability to induce or stabilize turn conforma-
tions. Thus, no optimization efforts were made to achieve enantiometric pure compounds.
The synthesis of the β-turn inducing spin label was tested using an approach, that was
based on the introduction of a nitrile group as carboxyl group precursor by a Strecker
reaction of the aldehyde spin label 23 (Figure 23, A). Using this transformation, a new
synthesis route for the azobicyclo spin label was developed (Figure 25). Thereby, the
Strecker product 24 is applied in a nucleophilic substitution with a cyclic anhydride 25
to form the nitrile substituted imide 26, which is capable to undergo the anionic cyclisa-
tion to yield cyclic framework of the target spin label. Finally, the desired β-turn inducing
spin label is obtained by acidic hydrolysis of the nitrile group.
Figure 25: Synthesis of the target spin label from an amino nitrile 24 prepared by Strecker synthesis.
Following approach A, the aldehyde 23 was treated with sodium cyanide (NaCN) and
ammonium chloride (NH4Cl) in ethanol upon addition of an aqueous ammonia solution
for 24 h at room temperature to form the amino nitrile 24. However, the reaction did
not succeed and the formation of an imine was observed by ESI-MS analysis. Several at-
tempts to optimize the reaction conditions by performing the reaction at low temperature
(0 ◦C) or by reducing the reaction time stepwise to 2 h also failed and led to the formation
of an imine. It is assumed, that the formed Strecker product 24 decomposes under the
applied reaction conditions upon elimination of hydrogen cyanide to form the observed
imine. Thus, the synthesis approach via the Strecker reaction was not continued, since
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the efforts to optimize the reaction failed.
Since the functionalization of the spin label by a nitrile group was highly preferable due
to its simple transformation into the carboxylic acid by hydrolysis, a synthesis approach
using the cyanohydrin reaction was used, which is shown in figure 26. Thereby, the imide
29 is formed in a Mitsunobu reaction between the cyanohydrine 28 and the cyclic imide
20. Then, the imide 29 undergoes the anionic cyclisation to yield the desired spin label
after hydrolysis of the nitrile group.
Figure 26: Synthesis of the target spin label from a cyanohydrin 28 prepared from the aldehyde 23.
The synthesis started with the formation of the cyanohydrin 28. Therefore, NaCN and
AcOH were added to a solution of the aldehyde 23 in diethylether (Et2O) and the reaction
was stirred at room temperature for 20 h. Analysis of the crude reaction by thin layer
chromatography (TLC) revealed the quantitative formation of the desired cyanohydrin 28,
which was also supported by ESI-MS analysis of the crude reaction. However, attempts
to purify the product by column chromatography failed, since the isolated fraction was
identified as the starting material 23. Thus, the formation of the cyanohydrin might be
reversible and the formed product 28 easily undergoes elimination of HCN to convert
back to the aldehyde 23.[83]
To prevent the conversion to the aldehyde 23, the cyanohydrin 28 was applied immedi-
ately without any further purification in the Mitsunobu reaction. Therefore, the crude
cyanohydrin 28, cyclic imide 20 and triphenylphosphine (PPh3) were dissolved at 0 ◦C in
THF and after addition of diisopropyl azodicarboxylate (DIAD), the reaction was stirred
at room temperature for 24 h. However, no product formation was observed by TLC
and ESI-MS analysis of the crude reaction revealed the presence of the aldehyde 23. A
possible reason for the failed Mitsunobu reaction might be a fast transformation of the
cyanohydrin 28 back to the aldehyde 23, whereby no reactant for the Mitsunobu reaction
remains. Therefore, the reaction was performed using diethyl azodicarboxylate (DEAD)
in order to achieve faster reaction rate due to the less sterically hindered DEAD. Never-
theless, this attempt also failed and the cyanohydrin based synthesis approach was not
continued, due to the instability of the cyanohydrin, which makes further transfomations
of this reactant extremely challenging.
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Therefore, the third synthesis approach C was applied, which was based on the addi-
tion of the cyclic imide 20 to the carbonyl group of the aldehyde 23 to form a secondary
alcohol 30. The latter could be transformed to carboxylic acid in further steps, as shown
in the developed synthesis approach (Figure 27).
Figure 27: Synthesis of the target spin label from an imide 30 prepared by nucleophilic addition.
To form the hydroxyl stubstituted imide 30, the cyclic imide 20 was deprotonated by the
base DBU to generate a nucleophile, that attacks the carbonyl group of the aldehyde 23.
Therefore, the aldehyde 23 was added to a solution of the cyclic imide 20 and DBU in
MeCN and the reaction was stirred at room temperature for 18 h. The product 30 was
isolated by column chromatography in a moderate yield.
Before performing the anionic cyclisation reaction, the secondary alcohol group should be
transformed into a carboxyl acid precursor, such as nitrile. Therefore, the alcohol 30 was
converted to a bromide 31 via a methanulfonate intermediate. The generated bromide
31 could then undergo nucleophilic substitution to form a nitrile 29, that could be hy-
drolysed to generate the carboxylic acid in later stage of the synthesis.
Thus, MsCl was added to a solution of the alcohol 30 and the base Et3N in DCM to
form the methansulfonate intermediate, that reacts in the next step to form the bromide
31. The reaction was stirred at 0 ◦C for 2 h but no formation of the methansulfonate
intermediate could be observed by TLC. Therefore, the reaction time was extended to
achieve the formation of the methansulfonate intermediate. However, the activation of
the secondary alcohol 30 was not successful propably due to the high sterical impact of
the neighboured cyclic imide and the pyrroline residue. Hence, because of the sterical
hindrance a successful nucleophilic substitution of the secondary alcohol 30 was highly
unlikely.
Thus, the synthesis was continued by the anionic cyclisation using the imide 30 as re-
actant. Applying the same reaction conditions for the anionic cyclisation as described
before lead not to the formation of the desired cyclic product. The TLC and ESI-MS
analysis of the crude reaction revealed the formation of multiple side-products. Hence, it
could be assumed that the anionic cyclisation does not tolerate additional substituents in
the allylic position of the reactant, since the reaction was successfully performed using the
imide 21. Therefore, the synthesis approach via an anionic cyclisation was not continued.
27
Taken into account all attempts to synthesize the desired β-turn inducing spin label,
there were no promising synthetical approaches left to test. Since the annealed ring sys-
tem of the target spin label needs to be constructed in a stepwise manner and a late-stage
functionalization by the carboxyl acid group is not possible, the synthesis of the desired
spin label is very challenging and highly limited in the design. Therefore, the design of
an alternative and readily accessible spin label was aimed, which is presented in the next
chapter of this work.
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4 Synthesis of Spin Labeled Azapeptides
As an alternative to the synthesis of the azabicyclo β-turn inducing spin label, an aza-
peptide based spin labeling approach was developed. This approach is inspired from the
work of Lubell et al., who demonstrated the versatile possibilities of modifying azapep-
tides by alkylation creating conformational constrained azapeptides by standard SPPS
(Figure 28).[84]
Figure 28: (A) Structural comparison between a natural peptide I, an azapeptide II and a Freidinger
lactam[85] III as lead structure for development of constrained azapeptides. (B) A selection of
constrained azapeptides, that can be prepared by modification of azaresidues. The compounds
IV, V and VI represent Aid[86], Nai[87] and alkylated residues.
Therefore, the idea of this labeling approach is based on the alkylation of an azapeptide
by a nitroxide spin label, which would adopt a β-turn conformation by incorporation of
a spin labeled aza amino acid residue.
Following the approaches of Lubell et al.[84,88], two different pathways for the synthesis of
the spin labeled azapeptide could be considered: One possibility is to perform the alky-
lation on resin bound azapeptide and to cleave the desired spin labeled azapeptide after
elongation from the resin. The second, a submonomer based approach, would require the
synthesis of a spin labeled azadipeptide that is coupled to a peptidyl resin. The azapep-
tide is then subsequently elongated by standard SPPS and yield the desired azapeptide
after cleavage from the resin.
In comparison to the submonomer approach, the SPPS based approach requires less syn-
thetical effort and makes the spin labeled azapeptides easily accessible. Since the spin
label can be attached by alkylation of the resin bound semicarbazone peptide, there is no
need of synthesizing a spin labeled amino acid for incorporation into the azapeptide, as
in the submonomer approach. The latter would require additional steps for the synthesis
of the spin labeled submonomer and optimization of the coupling conditions for the sub-
monomer by SPPS. Thus, the SPPS based approach of the spin labeled azapeptide was
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the method of choice.
Considering the SPPS based approach, the first step of the project design was to de-
termine a suitable spin label for the alkylation of the aza subunit.
Therefore, the following requirements for the spin label were taken into account: Most
importantly, the nitroxide spin label should possess a good leaving group to react in a nu-
cleophilic substitution with the deprotonated semicarbazone amine. In addition to that,
the spin label should be compatible with the conditions of microwave assistant SPPS,
since it is aimed to establish a reliable and general method for spin labeling of azapep-
tides. Thus, the spin label should exhibit a high nitroxyl stability to exclude reduction or
decomposition of the nitroxyl during synthesis. Moreover, the complexity of the spin label
should be minimal to make the spin label readily accessible. Finally, the attached spin
label should be conformationally rigid to ensure a fixed location of the nitroxide radical
unit and therefore, enable accurate EPR measurements of the target azapeptide.
Figure 29: Selection of suitable halide spin labels for the synthesis of spin labeled azapeptides by alky-
lation.
To match these requirements a range of spin labels were considered, that are illustrated
in figure 29. All spin labels are derived from the pyrroline or pyrrolidine structure due to
higher stability of five membered spin labels regarding reduction of the nitroxyl unit under
acidic or reductive conditions.[37] The pyrroline based spin labels were considered to be
promising candidates for the alkylation of the azapeptides, besause they match the above
mentioned criteria best. The bromide functionality is not sterically shielded, as in the
case of the spin labels in the third column and can be easily attacked by the nucleophile.
In addition to that, these spin labels could be readily prepared in few steps according to
already described procedures.
Finally, the conformational rigidity of these spin labels after their incorporation into the
peptide should be considered. Since both spin labels are based on the five membred pyrro-
line, that will be linked via a methylene to the azapeptide subunit, the rotation about the
C-N axis needs to be restricted. Therefore, the vinyl bromide pyrroline spin label turned
out to be the most promising candidate for the spin labeling of the azapeptide due to the
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vinylic bromide which could hinder the free rotation of the bound spin label around the
C-N axis by its sterical demand.
In the next step of the project an amino acid sequence for the spin labeled azapep-
tide was developed. With the aim to estabilsh a general protocol for introduction of the
spin labeled aza residue, a short polyglycine peptide sequence was developed (Figure 30).
Since the β-turn conformation is stabilized by a H-bond between the amide N-H of the
ith residue and the carbonyl O of the i+3th residue, the peptide should contain at least
four amino acid residues to enable preliminary structural analysis by CD spectroscopy.
Additionally, with the aim to establish a general synthetic protocol for spin labeled azapep-
tides, the peptide should contain some side-chain functionalities to test the applicability of
standard SPPS conditions according to the Fmoc/tBu protection group strategy. There-
fore, a 10-mer polyglycine based peptide flanked by two lysine residues and containing a
tryptophane residue at the N-terminus was chosen as model peptide.
Figure 30: Design of the model peptide to test the spin labeling approach of azapeptides.
Moreover, the incorporation of the basic amino acid lysine and the aromatic tryptophane
improves on the one hand the solubility of the peptide in aqueous solution and allows on
the other hand the calculation of the peptide concentration by UV/vis spectroscopy.
In the next sections of this chapter the synthesis of the designed spin labeled azapeptide
will be presented and discussed.
4.1 Synthesis of the Nitroxyl Spin Labeled Azapeptide by SPPS
The synthesis of a spin labeled azapeptide by SPPS was perfomed according to a modified
approach of Lubell et al., that comprises five main steps and is shown in figure 31.[91]
In the first step, a semicarbazone protected aza glycine is coupled to a resin bound peptide
yielding the aza-peptidyl resin. In the next step, the aza-peptidyl resin is treated with the
base trieethylammonium hydroxide (TEAH) to generate a nucleophile by deprotonation
of the acidic semicarbazone nitrogen, which undergoes a nucleophilic substituion with the
halogenated nitroxide spin label. After successfull alkylation of the azapeptide unit, the
N-terminal semicarbazone group is selectively cleaved under mild acidic conditions using
hydroxyl ammonium hydrochloride in pyridine. The next amino acid is coupled to the
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spin labeled aza-peptidyl resin using DIC as activating agent. In the next step, the aza-
peptidyl resin is elongated by microwave assistant SPPS to yield the desired azapeptide
sequence. Finally, the spin labeled azapeptide is cleaved from the resin by TFA with
addition of scavengers.
Figure 31: General scheme for the synthesis of a spin labeled azapeptide by alkylation.
For the beginning of the project, a semicarbazone protected aza glycyl residue was pre-
pared following the protocol of Lubell and coworkers.[91] Therefore, the semicarbazone
protected hydrazine 33 was reacted with chloroformate and DIPEA in DCM at 0 ◦C. The
reaction was stirred for 30min at room temperature to form an activated amine, that was
added to the Fmoc deprotected peptidyl resin 32. After agitating the peptidyl resin 32
for 18 h, a semicarbazone protected aza-peptidyl resin 34 was obtained (Figure 32). To
monitor the reaction process a test-cleavage was performed and and the crude azapep-
tide was analysed by ESI-MS. Therefore, a small amount of the alkylated aza-peptidyl
resin was agitated for 2 h at room temperature in a mixture of 2.5% water and 2.5% TIS
in TFA. The ESI-MS analysis revealed a quantitative reaction of the N-terminal glycine
residue.
After the formation of the semicarbazone protected aza-peptidyl resin 34 the spin la-
bel was attached to the resin bound azapeptide by alkylation (Figure 32). The bromide
nitroxyl spin label was prepared according to previously published procedures and was
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already described in chapter 3 of this work.
In the first step, the protected aza-peptidyl resin 34 was treated for 30min at room tem-
perature with TEAH in THF. Afterwards, the bromide spin label dissolved in THF was
added subsequently to the deprotonated semicarbazone aza-peptidyl resin. After agita-
tion of the mixture for 20 h at room temperature, a test-cleavage of the azapeptide 35
was performed to prove the formation of the alkylated azapeptide (Figure 32).
The ESI-MS analysis of the crude azapeptide revealed besides the spin labeled azapeptide
35 also the unreacted azapeptide 34. Thus, the conditions of the azapeptide alkylation
were optimized to reach a quatitative reaction conversion and to exclude the formation
of the unalkylated azapeptide during further synthesis.
Figure 32: Preparation of the aza-peptidyl resin by SPPS and the alkylation by the bromide spin label.
To optimize the alkylation step, variation of the following three reaction parameters was
considered: reaction time, amount of the bromide spin label and the choice of the base.
In a first approach, the alkylation was repeated under the same reaction condition as
described above, but the reaction time was elongated from 18 h to 72 h. However, the
ESI-MS analysis of the crude azapeptide from the test-cleavage revealed still the presence
of unalkylated azapeptide.
Therefore, the added amount of the bromide spin label was increased from 3 to 5 equiv-
alents, but the analysis by ESI-MS showed the presence of unreacted aza peptide 34.
The alkylation was additionally performed using 5 equivalents of the bromide spin label
for 72 h and 96 h. Nevertheless, unreacted azapeptide 34 was still detected by ESI-MS
analysis.
In the last approach, the base TEAH was exchanged with alternative bases. Therefore,
two bases were choisen, that were employed for the alkylation of azapeptides in previously
described procedures.[92]
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The first alternative was TBAH that has been tested by Lubell et al. in the course of
their azapeptide alkylation studies.[92] The base showed a lower conversion in comparison
to the TEAH, but still lead to product formation. The second alternative was tBuOK,
which has been employed for the deprotonation of protected aza dipeptides in solution
phase and also to perform bisalkylation of resin bound aza peptides.[92] The deprotonation
of the resin bound azapeptide was perfomed respectively using two fold molar excess of
TBAH and tBuOK in THF at room temperature for 30min. Afterwards, 3 equivalents of
the bromide spin label in THF were added and the peptidyl resin was agitated for 24 h
at room temperature.
However, none of these reaction conditions led to complete alkylation of the aza peptidyl
resin 34, as revealed by ESI-MS analysis.
The low conversion of the alkylation reaction could be attributed to the sterical impact of
the nitroxide spin label and the N-terminal benzophenone protecting group. In the course
of the nucleophilic substitution the deprotonated and sterically hindered semicarbazone
nitrogen attacks the bromide spin label, which has also a quite big sterical demand due
to its four methyl group substituents.
Therefore, elongation of reaction time and increasement of the amount of the bromide
spin label were probably ineffective. To address the incomplete alkylation, the sterical
demand of at least one reactant has to be reduced, which could be achieved by exchange
of the semicarbazone protecting group by a carbazone protection group. However, since
carbazone protected azapeptides are in general less stable,[93] the synthesis of the spin
labeled azapeptide was designed using a semicarbazone protecting azapeptidyl resin.
Since the alkylation of the resin bound azapeptide remained incomplete despite numerous
optimization efforts, the synthesis of the spin labeled azapeptide was continued (Fig-
ure 33).
In the next step, the N-terminal semicarbazone protecting group should be cleaved using
mild acidic conditions to avoid deprotection of the acid labile tBu and Boc protecting
groups of the lysine and tryptophane residues and the cleavage of the azapeptide from
the resin.
Therefore, the semicarbazone protected aza-peptidyl resin 35 was agitated at 60 ◦C for
18 h in a 1.5M solution of the hydrochloric salt of ammonium hydroxide in pyridine (Fig-
ure 33). Test-cleavage of the azapeptide 35 revealed neither the deprotected azapeptide
nor the semicarbazone azapeptide.
A possible reason for the failure of the semicarbazone deprotection might be the in-
compatibility of the nitroxyl spin label residue with the reaction conditions. Incubation
of nitroxyl spin labels in alcoholic solutions, that are saturated with hydrogen chloride, is
a common procedure to convert nitroxide radical to hydroxylamines.[94]
Therefore, the nitroxyl unit of the spin label residue was probably reduced to hydroxy-
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Figure 33: Attempted steps for the preparation of the spin labeled azapeptide.
lamine due to presence of hydrochloride in the deprotection solution and was subsequently
decomposed due to long exposure at elevated temperature in pyridine. The attempt to
perform the deprotection at room temperature and to reduce the reaction time to 5 h in
order to avoid the decomposition of the spin label also failed.
Thus, alternative deprotection conditions, as hydrogenolytic cleavage catalysed by Pd/C
or acidic cleavage by hydrochloric acid, were considered.[95,96] However, these were not
suitble for the SPPS of spin labeled azapeptides. Because the designed SPPS approach
is based on the Fmoc/tBu protection strategy and a Rink amide resin was used, strong
acidic conditions during deprotection would leave to deprotection of the tBu and Boc
protecting groups and to the cleavage of the azapeptide from the resin.
The cleavage of the semicarbazone protecting group under hydrogenolytic conditions
would be compatible with the SPPS approach, but not with the unsaturated spin la-
bel residue. The reduction of the double bond of the spin label would occur, which would
enhance the flexibility of the attached spin label.
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Since the alternative reaction conditions were not suitable for the initial SPPS approach,
the synthesis of the spin labeled azapeptide had to be redesigned. Therefore, the syn-
thetic approach was modified and a submonomer based strategy was developed, which is
introduced and discussed in the next sections.
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4.2 Synthesis of Spin Labeled Azapeptide by the Submonomer
Approach
In order to address the incompatibility of the semicarbazone deprotection conditions with
the nitroxyl spin label, the synthesis of the spin labeled azapeptide had to be modified.
Therefore, the application of a bromide spin label with a protected nitroxide radical,
which would avoid the side-reaction of the spin label residue during the semicarbazone
deprotection, was considered. Hence, a suitable protection group for the nitroxide radical
had to be chosen, that one the one hand is stable under the conditions of the SPPS and
on the other hand can be deprotected to recover the nitroxide radical in high yields. To
match these criteria two classes of protecting groups were taken into account: photolabile
and alkoxyamine protecting groups.
The protection of nitroxide radicals by photolabile protecting groups has been previ-
ously described, whereby 2-nitrobenzyl or coumarine derivatives are utilized as protection
groups.[97] The photolabile protection of nitroxide radicals would be advantageous in terms
of the orthogonality and the mild cleavage conditions, since the deprotection is achieved
by irradiation of the protected molecule in solution without the addition of any further
reagents.
The protection of the nitroxide radical by 2-nitrobenzyl derivatives takes place in a two-
step process, whereby the nitroxide radical is first converted into a hydroxylamine by re-
duction and then, undergoes a nucleophilic substitution with a 2-nitrobenzyl bromide.[97]
Since the nitroxide radical is reduced hydrogenolytically, the photolabile protection of the
bromide spin label would lead to reduction of the unsturated bond and therefore, to a
higher flexibility of the spin label linker. Thus, a modified synthesis route for the prepa-
ration of the photolabile protected bromide spin label would be required to maintain the
structure of the spin label.
In addition to that, the removal of the photolabile protection group results in the formation
of a hydroxylamine which is oxidized back to the nitroxide radical either spontaniously
upon exposure to air oxygen or by additional oxidant such as Cu(OAc)2.[97] Thus, the
conditions for the removal of the photolabile protecting group need to be tested and op-
timized for the spin label.
In contrast to the photolabile protection group strategy, the alkoxyamine protection is
a one-step procedure based on a radical recombination reaction between a nitroxide rad-
ical and one in-situ generated methoxy radical.[98] Therefore, the nitroxide radical of the
bromide spin label could be protected directly as methoxyamine without affecting the
double bond. Thereby, the rigidified linker of the spin label would maintain unaffected.
The removal of the methoxy protection group occurs oxidatively by treatment of the pro-
tected molecule with m-CPBA and results in formation of the nitroxide radical.[98] In
contrast to the deprotection conditions of a photolabile protecting group, the conditions
of the oxidative cleavage are harsher and might be problematic in the presence of oxida-
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tion prone functionalities in the target molecule.
However, taking into account the requirement to develop a modified synthetic route for a
photolabile protected spin label and to establish optimized conditions for nitroxyl recov-
ery, the alkoxyamine protection group strategy was considered to be a better alternative.
After determining a suitable protecting group for the nitroxide radical, the incomplete
alkylation of the resin bound semicarbazone protected azapeptide had to be addressed.
Since the low reaction conversion could be mainly attributed to the sterical impact of
both reactants, performing the alkylation between the methoxy protected bromide spin
label and a protected azadipeptide might enhance the reaction yields. The protected spin
labeled azadipeptide would serve as a building block for incorporation into the peptide
by SPPS. Thus, the initially designed SPPS approach was exchanged by a submonomer
approach, that is illustrated in figure 34.
Figure 34: General scheme for the preparation of the spin labeled azapeptide by the submonomer ap-
proach via SPPS.
In the first step, a methoxy protected bromide spin label reacts under basic conditions
with a semicarbazone azadipeptide to form the alkylated azadipeptide submonomer fol-
lowed by treatment with TFA to remove the tBu protection group. The submonomer
is then coupled to the resin bound peptide to yield a semicarbazone protected alkylated
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aza-peptidyl resin. In the next step, the semicarbazone is cleaved under mild acidic con-
ditions and the deprotected azapeptide is elongated by the next amino acid using DIC as
activation agent. Afterwards the azapeptide is elongated by standard microwave assistant
SPPS. Since the methoxy protecting group needs to be removed oxidatively by m-CPBA,
it was decided to perform the oxidative cleavage with the side-chain protected and resin
bound azapeptide to avoid side reactions.
Finally, the spin labeled azapeptide is cleaved from the resin by TFA.
In the next sections the synthesis of the methoxy protected spin label and the spin labeled
azapeptide will be presented, followed by the discussion of the CD spectroscopic analysis
of the alkylated azapeptide.
4.2.1 Synthesis of the Spin Labeled Azadipeptide Submonomer
First, the spin label 18 was protected according to a previously published procedure.[98]
Therefore, H2O2 was added to a mixture of FeSO4 and the spin label 18 in DMSO at
15 ◦C to generate in-situ the methoxy radical, which subsequently reacted with the ni-
troxide radical of the spin label 18 (Figure 35). The reaction was carried out for 30 h and
the methoxy protected spin label 40 was obtained in a good yield after chromatographic
purification.
Figure 35: Synthesis of the methoxy protected bromide spin label.
Then, the azadipeptide submonomer 42 was syntesized by a previously published pro-
tocol (Figure 36).[96] In the first step, benzophenone hydrazine 41 reacted with benzyl
chloroformate for 1 h at 0 ◦C to form the activated intermediate, that was treated with
DIPEA and reacted finally with tBu protected glycine for 16 h to form the semicarbazone
protected azadipeptide tBu ester 42 (Figure 36).
Figure 36: Synthesis of the tBu protected azadipeptide.
With the methoxy protected spin label 40 and the semicarbazone protected azadipep-
tide 42 in hands the alkylation (Figure 37) could be perfomed following a modified
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procedure.[91]
Figure 37: Alkylation of the azadipeptide by the methoxy protected spin label and the subsequent de-
protection of the tBu group.
Therefore, 2 equivalents of TEAH were added to a solution of the semicarbazone pro-
tected azadipeptide 42 in THF at 0 ◦C and the reaction was stirred for 30min. After
the deprotonation of the semicarbazone protected azadipeptide, the methoxy protected
bromide spin label 40 was added in a 3-fold excess and the reaction was stirred for 20 h
at room temperature. TLC analysis of the crude product revealed the formation of one
main product, which was identified as the alkylated azadipepde 43 after chromatographic
purification.
Finally, the tBu protection group was removed by stirring the alkylated azadipeptide in
a mixture of TFA/DCM at room temperature for 2 h. After the removal of the solvent,
the deprotected azadipeptide 43 was obtained in a quantitative yield and used without
further purification.
After the successful synthesis of the methoxy protected spin labeled azadipeptide 44, the
incorporation of the alkylated monomer into the model peptide by SPPS was performed.
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4.2.2 Application of the Spin Labeled Submonomer in SPPS
To test the the compatibility of the spin label protected azadipeptide 44 under SPPS con-
ditions and to establish a general protocol for its incorporation, the spin label protected
azadipeptide 44 was incorporated into the polyglycine based model peptide (Figure 38).
Figure 38: Coupling of the methoxy protected and spin labeled azadipeptide to the peptidyl resin followed
by SPPS of the spin labeled azapeptide.
Therefore, a peptidyl resin was prepared by microwave assistant SPPS (for more details,
see chapter 7) on a Rink amide MBHA resin with a low loading capacity. The low load-
ing capacity of the resin was important to minimize aggregation of the growing peptide
chains and therefore, sterical hindrance during the coupling steps. Thus, the choice of a
low loaded resin could enhance the coupling efficiency of the bulky alkylated azadipeptide.
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After the successful preparation of the peptidyl resin the alkylated azadipeptide 44 was
attached using HOAt/HATU as activation agents and DIPEA as base for the coupling re-
action (Figure 38). In the first step, the building block 44 was treated with HOAt/HATU
upon addition of DIPEA in DMF for 5min at room temperature. Subsequently, the pre-
activated monomer was added to the peptidyl resin and the mixture was agitated for 19 h
at room temperature until the completion of the coupling reaction was indicated by the
ninhydrin color test[99] (for detailes, see chapter 7). Finally, the ESI-MS analysis of the
crude peptide 45 from a test-cleavage revealed the formation of the alkylated azapeptide
45.
In the next step, the semicarbazone protecting group was removed using the hydrochlo-
ric salt of ammonium hydroxide in pyridine at 60 ◦C for 16 h (Figure 38). The reaction
perceed quntitatively yielding the deprotected azapeptide 46, which was proved by ESI-
MS analysis of the crude peptide from a test-cleavage.
Then, the alkylated azapeptide 46 was elongated by the next glycine residue under mild
conditions, by employing a symmetric anhydride activation strategy (Figure 38). The
usage of DIC as activating agent was considered to result in a higher coupling efficiency
due to the formation of relatively compact anhydride, which could approach the sterical
demanded aza glycine residue easily.
For the formation of the anhydride, Fmoc-Gly-OH was reacted for 30min with DIC at
0 ◦C in DCM. Then, the crude glycine anhydride was added in 5-fold excess to the aza-
peptidyl resin 46 in DMF and was agitated for 16 h at room temperature. The reaction
was monitored by the ninhydrin color test[99] and the ESI-MS analysis of the crude aza-
peptide from a test-cleavage approved a complete conversion of the aza amino group.
After the successful attachment of the glycine residue to the azapeptidyl resin 46, the aza-
peptide 47 was elongated using standard microwave assistant SPPS (Figure 38). There-
fore, the amino acids glycine, tryptophane and lysine were employed in 4-fold excess using
HAOt/HATU as activating agents and DIPEA as base in DMF. The coupling and depro-
tectetion conditions are described in more detail in chapter 7.
Afterwards, N-terminal capping was performed by treating the aza-peptidyl resin 47 for
5min in a solution of 20% acetic acid anhydride in DMF to protect the N-terminus from
side-reactions during remaining synthesis.
The formation of the desired azapeptide 48 was confirmed by ESI-MS analysis of the
crude peptide from a test-cleavage.
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Finally, the methoxy protection group of the spin labeled residue should be removed under
oxidative cleavage conditions (Figure 39).
Figure 39: Attempted deprotection of the methoxy protection group on resin bound azapeptide.
According to the general procedure, the methoxy group deprotection is carried out in
solution phase using a 2-fold excess of m-CPBA in DCM at room temperature. However,
to prevent side-reactions with the side-chains of the azapeptide the oxidative cleavage was
attempted on the resin bound azapeptide.
Therefore, the azapeptidyl resin 48 was incubated at room temperature with a solution of
m-CPBA in DCM for 10min, whereby the deprotection was monitored by a test-cleavage
after 5 and 10min. ESI-MS analysis of the crude azapeptide revealed no formation of the
nitroxyl labeled azapeptide 49 and no presence of the methoxy protected azapeptide 48.
A possible reason for the failure of the deprotection could be side-reactions with the
spin label residue, such as epoxidation of the double bond moiety. Additionally, the in-
compatibility of the resin bound azapeptide under the oxidative conditons could lead to
degradation of the azapeptide.
However, the alkylated azapeptide was cleaved from the resin by incubating the peptidyl
resin in a TFA cleavage coctail for 2 h at room temperature (Figure 40).
Afterwards, the isolated crude azapeptide 50 was purified by reverse-phase high pressure
liquid chromatography (RP-HPLC) to eluate the desired azapeptide 50, which was con-
firmed by ESI-MS analysis.
After the successful isolation of the methoxy protected azapeptide, a further attempt to
remove the methoxy group from the purified azapeptide 50 was made. Therefore, the
oxidative cleavage was performed at lower temperature (0 ◦C) and a solution of m-CPBA
in DCM was added slowly to keep the concentration of the oxidant low and avoid side-
reactions with the tryptophane and lysine side-chains (Figure 40).
However, the oxidative cleavage failed to yield the desired spin labeled azapeptide 51.
Since tryptophane residues are commonly known to be sensitive towards oxidation,[100]
the ESI-MS spectrum of the crude azapeptide was analyzed for products containing an
additional hydroxyl functionality, but there was no corresponding m/z ratio found in the
spectrum.
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Figure 40: Cleavage of the azapeptide from the resin and the attempted deprotection of the methoxy
protection group in solution phase using the purified azapeptide.
Another possible side-reaction was a epoxidation of the double bond of the spin label,
but analysis of the ESI-MS spectrum showed no formation of the corresponding side-
product.
Therefore, it can be concluded that the conditions of the oxidative cleavage are not
compatible with the alkylated azapeptide and lead probably to decomposition of the
azapeptide during the deprotection. Since there are no alternative deprotection condi-
tions, except using H2O2 as oxidant, which would result in the same reaction outcome,
no further attempts were made to remove the methoxy protection group.
4.2.3 Conformational Analysis of Methoxy Protected Azapeptide
After the synthesis of the methoxy protected spin labeled azapeptide was completed, the
purified azapeptide 50 was analyzed by circular dichroism (CD) spectroscopy to evalu-
ate the conformation inducing properties of the alkylated aza residue. According to the
findings of Lubell et al., alkylated azaglycine residues induce or stabilize different types
of β-turn conformations, which is strongly dependent on the peptide sequence and the
position of the aza amino acid residue.[101] Therefore, to evaluate the conformational effect
of the alkylated aza residue, it would be necessary to synthesize a set of different spin
labeled azapeptides, that are derived from peptides showing a certain degree of β-turn
conformation.
In natural proteins segments with turn conformations are often identified as connecting
units between higher ordered domains, as α-helices or β-sheets.[7] Therefore, the stability
and conformation of the turn motif is strongly influenced by the overall structure of the
protein.
44
There are only a few examples of peptides known, that posses an isolated β-turn conforma-
tion, like the 6-mer GhRP peptide, that served as model peptide in several conformational
azapeptide studies.[101]
Thus, it is fairly unlikely to see the turn inducing effect of the aza residue in relatively
short peptides, unless the peptide sequence itself exhibit a high propensity to adopt a
turn conformation.
Taking these aspects into account, the synthesiszed methoxy protected azapeptide was
analyzed by CD-spectroscopy with the aim to receive first hints regarding the inducing
properties of the alkylated aza residue. Additionally, the methoxy protection group of the
nitroxyl unit was assumed to have no effect on the peptide conformation, because of the
small size and the position on the side-chain of the turn inducing residue.
For the CD-spectroscopical analysis a 50µM solution of the methoxy protected azapep-
tide in MeOH was employed and the measurement was perfomed in a wavelength range
between 260 and 190 nm to cover the absorption region of the conformation dependent
chromophors. Analysis of the resulting CD-spectrum (see chapter 8) gave no hint on the
presence of a β-turn or other types of turn conformation.
For a β-turn conformation a maximum in the wavelength range between 190-200 nm and a
minimum at 210 nm would be expected according to the literature.[102] The CD-spectrum
of the methoxy protected azapeptide showed a minimum at 190 nm, which is typically for
unordered structures, and a maximum at 226 nm, which can be assigned to absorbtion of
the tryptophane side chain.[103]
Since the sequence of the synthesized azapeptide is rather short and exhibit no turn
propensity, the results from the measurement were not surprising.
Thus, to receive information regarding the inducing effect of the spin labeled aza residue
a set of spin labeled azapeptides with distinct turn conformation should be prepared and
analyzed. By this, no conclusions on a stabilizing or destabilizing effect of the spin labled
aza residue could be drawn.
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5 Application of the α-TOPP Spin Label in Peptide
Synthesis by Native Chemical Ligation
EPR spectroscopy is a widly used technique to analyse interactions or structural changes
in protein systems. Therefore, the analysed proteins need to be labeled by paramagnetic
labels, which are often based on nitroxide radicals. Nitroxide radical spin labels can be
detected by EPR spectroscopy, which enables to measure distances within double spin
labeled proteins or to examine the orientation of spin labeled transmembrane proteins by
double pulsed EPR techniques such as PELDOR or DEER.[1]
To obtain accurate measurements by EPR spectroscopy, the incorporated spin labels have
to fullfill two crucial requirements: One the one hand the used spin label should exhibit a
high degree of rigidity to avoid movement of the paramagnetic unit and on the other hand
the disturbance of the local peptide structure by incorporation of the spin label should
be as minimal as possible. This would allow to tranfer the structural data obtained from
EPR measurements of spin labeled proteins to the native proteins.
The labeling of peptides can be achieved either by direct incorporation of spin lables, based
on amino acids bearing a nitroxide unit, or by side-directed spin labeling (SDSL).[13]
The SDSL approach is based on click reactions between the side-chains of the peptide
and the appropriate spin label.[49,106] One of the most applied SDSL approaches utilizes
the methanethiosulfonate (MTSL) nitroxide spin label, that readily reacts with the thiol
groups of cysteine containing peptides to form a disulfide bond and thereby attaches to
the peptide.[45,107]
Whereas smaller protein systems can be labeled either by direct incorporation through
SPPS or by SDSL, the spin labeling of larger protein systems is mostly restricted to the
SDSL approach. This is caused by the limitations of the automated SPPS for proteins
containing more than 100 amino acids.
In terms of rigidity, the amino acid spin labels are superior to the spin labels that are
attached through a flexible linker via SDSL. Therefore, the analysis of larger protein
systems by EPR spectroscopy could be further improved by using rigid amino acid spin
labels.
A possibility to circumvent the limitations of the SPPS of spin labeled peptides is to
combine the spin labeling with the native chemical ligation (NCL).[104] NCL is a tech-
nique to synthesize large proteins in a stepwise manner by ligation of two or more protein
fragments.[6,105] This technique not only provides the synthetic access to large naturally
occuring protein systems, but allows also to manipulate the protein system by different
labels depending on the further application.
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A crucial requirement to use this approach is the presence of cysteine residues in the
protein, because the ligation is based on the reaction between the thiol group of an N-
terminal cysteine residue and a C-terminal thiolester, which leads to the formation of an
amide bond.[6,105]
However, the usage of spin labeled peptide fragments for NCL might be problematic due
to the required coexistence of free thiol groups and nitroxide radical containing spin la-
bels, that are both redox active. Whereas the cysteine residues are prone to oxidation
by formation of disulfide bridges[108], some nitroxide radicals are susceptible to convert
to nitroxyl amines under reductive conditions and therefore to lose their paramagnetic
property.[89]
Therefore, to synthesize spin labeled and cysteine containing proteins by SPPS, both re-
dox processes should be suppressed to preserve the thiol group and the nitroxide radical.
To maintaine the thiol groups of cysteine residues, the ligation is performed upon addition
of reducing agents, like TCEP, and under unaerobic conditions.[109,110]
However, these conditions are incompatible with the nitroxide radical spin labels, due to
their propensity to be reduced to the corresponding hydroxyl amines. Thus, to keep the
nitroxide radical unaffected during the synthesis of the spin labeled peptide and the NCL,
the nitroxide radical needs to be protected by an orthogonal protecting group.
This protecting group should be stabile under the standard SPPS conditions using the
Fmoc/tBu protecting group strategy. Furthermore, the protecting group should be re-
moved selectively to recover the nitroxide radical. Taking these requirements into account,
the photolabile protecting group strategy developed by Seven et al. is a promising tool to
protect nitroxide radicals during the SPPS and the NCL.[97] The photolabile protecting
groups, such as 2-nitrobenzyl, can be easily removed by irradiation without generating
side-products or affecting the unprotected peptide.
Thus, in the course of this project, a protocol for the application of the photolabile pro-
tected α-TOPP spin label in peptide synthesis by NCL should be established (Figure 41).
Therefore, the semi-rigid α-TOPP spin label, that was a promising candidate for study-
ing peptide conformations in fromer studies[4], should be synthesized and protected by
a 2-nitrobenzyl based protecting group. Afterwards, the photolabile protected α-TOPP
spin label should be incorporated into a model peptide with a N-terminal cysteine residue
via SPPS and finally, be applied in NCL (Figure 41).
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Figure 41: General scheme for the application of the α-TOPP spin label in peptide synthesis by NCL.
To test the NCL, two peptide fragments should be synthesized, that would recombine by
NCL to the model peptide B (Figure 42). After successfull ligation of the two peptide
fragments, the photolabile protecting group should be removed by irraditon with UV light
(365 nm) yielding a spin labeled cysteine containing peptide.
For the start, the α-TOPP spin label was synthesized following the procedures described
by Stoller et al. and Halbmair et al.[3,4] However, it was aimed to optimize the synthesis
process in terms of time efficiency and purification, since some transformations in the
the linear synthesis of the α-TOPP spin label require long reaction times and elaborate
purification steps.
For the nitroxyl protection of α-TOPP spin label a 2-nitrobenzyl based protection group
was chosen, that can be installed in a two-step process described by Seven et al.[97]
In the next step, an appropriate model peptide was chosen to proof the concept. The
modified transmembrane model peptide WALP24 was considered to be a suitable candi-
date, since it was labeled by the α-TOPP spin label in previous studies.[4]
Therefore, the sequence of the modified WALP24 peptide was slightly changed by sub-
stitution of the leucine residue in position 12 by a cysteine residue to enable its synthesis
via NCL. Additionally, the leucine residue in position 14 should be substituted by the
photolabile protected α-TOPP spin label, which led to the model peptide illustrated in
figure 42.
Figure 42: Designed peptides for the application of the α-TOPP spin label in peptide synthesis by NCL.
A represents the sequence of the WALP24 model peptide and B is the cysteine and α-TOPP
(X) spin labeled peptide sequence derived from the WALP24 peptide.
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In the next sections of this chapter the synthesis of the photolabile protected α-TOPP
spin label and the cleavage of the photolabile protecting group will be discussed.
5.1 Synthesis of Photolabile Protected α-TOPP Spin Label
The synthesis of the α-TOPP spin label was performed according to the protocols of
Stoller et al. and Halbmair et al.[3,4], whereby some attempts were made to make the
liniar synthesis more time efficient.
In the first steps of the synthesis, the amino and carboxyl group of the commercial avail-
able L-4-hydroxyphenylglycine 52 were protected in a two-step procedure by a benzylester
and a benzyl group. Then, the hydroxyl group was converted into a triflte 55, that serves
as good leaving group in the subsequent synthesis steps (Figure 43).
Figure 43: Synthesis of the triflate spin label from the commercial available L-4-hydroxyphenylglycine.
First, the amino group of the L-4-hydroxyphenylglycine 52 was protected under Schotten
Baumann conditions. Thereby, the glycine derivative 52 was treated with CbzCl in a
mixture of 1.4-dioxane and aqueous sodiumbicarbonate solution for 1 h at room temper-
ature.
Next, benzyl bromide and NaHCO3 were added to the crude Cbz protected intermediate
in DMF and after stirring the reaction for 20 h at room temperature, the benzyl protected
intermediate 54 was isolated after purification by column chromatography in a good yield
(Figure 43).
After the protection of the amino and the carboxyl group, the hydroxyl group was con-
verted to a triflate by nucleophilic substitution with trifluoromethanesulfonic anhydride
(Tf2O). Therefore, the protected intermediate 54 was treated with pyridine in DCM to
deprotonate the hydroxyl group, which readily react with Tf2O to yield the correspond-
ing triflate 55 in 40min at room temperature (Figure 43). Since some by-products were
detected by TLC analysis, the crude product 55 was purified by column chromatography
to obtain the desired triflate in a good yield.
In the next steps of the synthesis, the triflate group was converted in a Miyaura cross-
coupling reaction to a boronic ester, that was hydrolyzed to obtain the boronic acid (Fig-
ure 44). However, before performing the borylation reaction, the Cbz protection group of
the intermediate 55 had to be exchanged by the Bn protecting group (Figure 44) in order
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to avoid the formation of a racemic product.[3]
Figure 44: Synthesis of the boronic acid spin label from the triflate spin label.
Following a two-step procedure, the protected glycine derivative 54 was first stirred upon
addition of a high excess of dimethyl sulfide (Me2S) in TFA for 19 h at room temper-
ature. Afterwards, the unprotected glycine intermediate was used without any further
purification. In the next step, the amino and the carboxy group of the crude intermediate
were protected by benzyl groups. Therefore, the crude intermediate and NaHCO3 were
dissolved in dimethyl sulfoxide (DMSO) and after the addition of benzyl bromide (BnBr)
the reaction was stirred for 21 h at room temperature to yield the benzyl protected prod-
uct 56 in a moderate yield after purification by column chromatography (Figure 44).
In the next step, the benzyl protected triflate 56 was converted into the boronic ester 57
by Miyaura borylation.
Therefore, the triflate 56 was dissolved under dry and anaerobic conditions in 1,4-dioxane
and after the addition of B2(pin)2, the base KOAc, 1,1’-bis(phenylphosphino)ferrocene
(dppf) and the catalyst PdCl2(dppf) the reaction was stirred for 6 h at 80 ◦C (Figure 44).
The desired boronic ester 57 could be obtained in a good yield after purification by col-
umn chromatography.
Since boronic acids are superior to boronic esters in Chan-Lam cross-coupling reactions in
terms of reactivity, the boronic ester 57 was transformed into the corresponding boronic
acid 58.
For the hydrolysis, the boronic ester 57 was stirred with ammonium acetate (NH4OAc)
and sodium periodine (NaIO4) in a mixture of water/acetone for 54 h at room temperature
(Figure 44). Thereby, the NaIO4 was used as a mild oxidant to convert the formed pinacol
into acetone. The desired boronic acid 58 was obtained without further purification in a
good yield.
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The following Chan-Lam coupling of the boronic acid 58 with the piperazine-2,6-dione
61 is the key step in the synthesis towards the α-TOPP spin label, since the framework
of the α-TOPP spin label is formed.
Therefore, the piperazine-2,6-dione 61 was synthesized in two steps by a modified synthe-
sis route. Although the preparation of the nitroxyl precursor 61 has been described by
Stoller et al. and Wegner [111], it was aimed to optimize the original synthesis (Figure 45)
by usage of more benign starting materials.
Figure 45: Comparison of the original preparation of the piperazine-2,6-dione by Wegner (A) with the
optimized synthesis (B).
Thus, the synthesis started with the commercially available hydrochloride salt 62 that
was converted into the free amine and subsequently dimerized to form the dinitrile in-
termediate 60, which was converted to the target nitroxide precursor 61 following the
described procedure by Wegner (Figure 45).[111]
In the first step, the commercial available hydrochloride 62 was dissolved in water and
treated with a 10% aqueous solution of NaHCO3, until the reaction solution reached pH7.
Afterwards, the desalted amine was extracted with ethyl acetate (EtOAc) and isolated by
removal of the solvent under reduced pressure (Figure 45).
For the formation of the dinitrile 60, the amine was allowed to stand at room temperature
under reduced pressure (30-50mbar). After 5 d of reaction quantitative formation of the
dimer 60 was observed (Figure 45). The dinitrile 60 was obtained without further purifi-
cation in a moderate yield of 30% over two steps from the hydrochloride 62. Thereby,
the low yield is mainly caused by the volatility of the desalted amine.
The isolated dinitrile 60 was hydrolysed and subsequently converted to the desired cyclic
dione 61 by condensation according to the protocol of Wegner [111]. Therefore, the dimer
60 was dissolved in 68% aqueous sulfuric acid and stirred at room temperature for 4 d.
The cyclic dione was isolated after basic work-up in a moderate yield of 24%, which is
probably caused by its instability[111] under basic conditions (Figure 45).
However, the attempt to optimize the procedure for the synthesis of the cyclic dione can
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be assumed as successfull. By modifying the synthesis of the dinitrile 60, the usage of
KCN and purification steps by destillation could be avoided.
After the successful synthesis of the cyclic dione 61, the linear synthesis of the α-TOPP
spin label was continued with the Chan-Lam amination of the boronic acid 58.
The Chan-Lam cross coupling is a N-arylation reaction of amines, amides or imides and is
performed under mild conditions. The reaction works at room temperature upon the ad-
dition of weak bases and Cu2+ salts as catalyst. Moreover, the reaction is performed under
aerobic conditions, since the atmospheric oxygen serves as oxidant for the re-oxidation of
the copper catalyst to maintain the catalytic process.[112]
According to the procedures by Stoller et al. and Halbmair et al. the desired cross-
coupling product 63 was formed in 14 d, which makes the synthesis of the α-TOPP spin
label quite time consuming.[3,4]
Hence, to reduce the reaction time an optimization of the reaction conditions was at-
tempted. During research on the Chan-Lam cross-coupling reaction, a published study
turned out to be particularly interesting regarding optimization of reaction conditions.[112]
The study revealed the oxygen pressure to be an important reaction parameter, that have
a big impact on the yield.[112]
Briefly, the authors found out, that the yields of the Chan-lam coupling increased at
higher oxygen pressures.[112] Since the oxygen pressure might also have an effect on the
reaction rate, the Chan-Lam coupling of the cyclic imide 61 with the boronic acid 58 was
performed applying the same reaction conditions as described by Halbmair et al.[4] but
under higher oxygen pressure (Figure 46).
Figure 46: Chan-Lam coupling between the boronic acid spin label and the piperazin-2,6-dione.
Therefore, the boronic acid 58 and the cyclic imide 61 were stirred upon addition of
triethylamine, anhydrous Cu(OAc)2 and molecular sieves in DMSO at room temperature
under an oxygen pressure of 3 bar (Figure 46). The reaction was monitored by TLC and
showed a complete conversion after 3 d.
The coupling product 62 was isolated after purification by column chromatography in a
good yield. By performing the reaction under the same conditions as described by Halb-
mair et al., only traces of the desired coupling product 63 were detected by TLC after
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3 d of reaction.
Thus, the attempt to optimize the rate of the key reaction was successful, since it was
possible to reduce the reaction time from 14 to 3 d.
In the next steps of the synthesis, the preparation of the photolabile proteted α-TOPP
spin label was completed (Figure 47).
Figure 47: Synthesis of the 2-nitrobenzyl and DMNB protected α-TOPP spin label from the cyclic amine.
Therefore, the benzyl protecting groups of the coupling product 3 were removed to pro-
tect the amino group by the base labile Fmoc group, which is suitable for the standard
SPPS.
The removal of the benzyl groups was achieved hydrogenolytically using the Pearlman‘s
catalyst (Pd(OH)2/C). For the benzyl deprotection, the coupling product 63 was dissolved
in a mixture of MeOH/DCM and stirred upon addition of the palladium catalyst at room
temperature for 20 h under a hydrogen atmosphere (Figure 47). Afterwards, the crude
intermediate was used in the next step without any further purification.
To install the Fmoc protecting group, the deprotected intermediate was reacted with N -
(9-fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) and NaHCO3 in DMF at room
temperature for 24 h (Figure 47). Afterwards, the Fmoc protected spin label precursor 64
was isolated by column chromatography in a moderate yield.
In the last two steps of the linear synthesis, the nitroxide radical was generated by oxi-
dation and finally, protected by the photolabile nitrobenzyl protecting group (Figure 47).
For the oxidation of the secondary amine, the spin label precursor 64 was reacted with
m-CPBA in DCM at room temperature for 5 h (Figure 47). After the conversion to the
corresponding nitroxide radical the crude α-TOPP spin label 65 was purified by column
chromatography.
The spin label 65 was obtained in a good yield and was subsequently protected in the
next step by a 2-nitrobenzyl group following the published two-step procedure by Seven
et al.[97]
First, the nitroxide radical 65 was converted by hydrogenation into hydroxyl amine to
react in the following nucleophilic substitution reaction with 2-nitrobenzyl bromide.
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Therefore, the spin label 65 was dissolved in THF and stirred upon addition of Pd/C un-
der a hydrogen atmosphere for 2 h at room temperature (Figure 47). The reduction of the
nitroxide radical 65 was monitored by TLC and after the conversion was complete, the
reaction mixture was flushed with argon to remove the hydrogen and prevent oxidation
of the hydroxyl amine.
Then, Et3N and 2-nitrobenzyl bromide were added to the reaction mixture and the reac-
tion was stirred for 9 h at room temperature (Figure 47). The photolabile protected spin
label 66 was obtained after purification by column chromatography in a low yield.
The low yield could be explained by the formation of the 2-nitrobenzyl protected carboxyl
by-product. Hence, a suitable carboxyl protecting group would be required to supress the
side-reaction.
Additionally, the photolabile protection of the nitroxide radical was performed using
the same conditions as described before, but using 4,5-dimethoxy-nitrobenzyl bromide
(DMNB-Br) for protection (Figure 47). Since the DMNB group is known to have higher
cleavage rates in comparison to the 2-nitrobenzyl group, the DMNB protected spin label
67 was synthesized as an alternative for the 2-nitrobenzyl protected spin label 66.
5.2 Testing the Removal of the 2-Nitrobenzyl and the DMNB
Protecting Groups
In the next step of the project, the cleavage conditions for the two photolabile protected
spin labels 66 and 67 were tested. This step was crucial for the project, since the usage
of the photolabile protected α-TOPP spin label in NCL relies on the efficient recovery of
the paramagnetic nitroxide radical after the ligation reaction.
In the studies of Seven et al. various spin labels were protected by photocleavable groups
and the nitroxide radical could be readily recovered in high yields by a two-step process.[97]
After irradiation of the samples with UV light (365nm) a hydroxylamine intermediate is
formed, which is usually easily oxidized to the corresponding nitroxide radical by air
oxygen without the usage of additional oxidants, such as PbO2 or Cu(OAc)2.[97] To find
the optimum cleavage conditions, the two photolabile protected spin labels 66 and 67
were irradited for 2 h with UV light (365 nm) in different solvent systems. Thereby, the
cleavage process was monitored by RP-HPLC analysis of samples, that were taken in 10
min intervalls from the reaction mixture, to observe the formation of the nitroxide radical
65.
Due to better solubility of the protected spin labels 65 and 66, the reaction was performed
in a mixture of MeCN/H2O (v/v, 60/40) and in a mixture of basic carbonate buffer
(pH=8.4) and MeOH (v/v, 1/3). The latter was expected to yield the better results,
since the recovery of the nitroxide radical 65 from the hydroxylamine intermediate is more
efficient under basic conditions.[97] Figure 48 shows the RP-HPLC analysis of cleavage
process for the 2-nitrobenzyl protected spin label 66 in the MeCN/H2O mixture. The
54
HPLC analysis was performed using an analytical C18 column and the solvents A (di-
demineralized water containing 0.1% TFA) and B (MeCN containing 0.1% TFA). For a
good seperation of the reaction products a gradient from 10 to 40% B in 30 min was
applied.
Figure 48: Monitoring of the 2-nitrobenzyl deprotection reaction by RP-HPLC.
Before irradiation with UV light (0min), the HPLC-chromatogram shows one signal at
a retention time (tR) of 19.2min which corresponds to the 2-nitrobenzyl protected spin
label 66. After irradiation of the sample for 10min, the formation of another product
with a retention time of 6.3min is observed, but the fraction was not identified as the
desired nitroxide radical by ESI-MS analysis.
During the first 40min of irradiation only a slight decrease of the protected spin label 66
could be observed, which indicated a bad cleavage efficiency of the 2-nitrobenzyl group.
After 50min of irradition, the intensity of the signal corresponding to the protected spin
label dropped and a nearly complete disappearance of the signal was observed after 2 h
of irradiation.
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However, no of the fractions corresponding to the signals at retention times of 18.3min,
11.4min, 8.4min, 7.5min or 6.3min could be identified by ESI-MS analysis as the desired
nitroxide radical 65 or the hydroxylamine species.
Performing the irradiation in a mixture of carbonate buffer and MeOH led to the same
results, whereby no formation of the nitroxide spin label 65 could be detected.
Therefore the deprotection was tested using the same conditions, but with the DMNB
protected spin label 67. The DMNB protected spin label 67 was dissolved in a mixture
of carbonate buffer and MeOH (v/v, 1/3) and was irradiated at 365 nm for 2 h, whereby
the first three samples of the reaction mixture were taken in 5min intervals and the re-
maining samples in intervalls of 30min. The shorter intervals for the analysis during the
first 15min of reaction were chosen, because the cleavage of the DMNB protecting group
is in general faster than of the 2-nitrobenzyl group. Therefore, to identify the optimum
irraditiation time the first 15min of irradiation were monitored in more detail.
The RP-HPLC analysis of the cleavage progress for the DMNB protected spin label 67 is
illustrated in figure 49. The HPLC-analysis was performed using the same conditions as
for the 2-nitrobenzyl protected spin label 66.
Before irradiation with UV light (0min), the HPLC-chromatogram shows a main signal
at a retention time of 18.5min, which corresponds to the DMNB protected spin label 67.
After irradiation of the sample for 5min, a significant decrease of the signal corresponding
to the DMNB protected spin label 67 could be observed. In addition to that, formation of
other products with retention times of 14.9min, 12.3min and 6.3min could be observed.
After 30min of irradiation, the signal corresponding to the protected spin label 67 nearly
disappeared, which indicated a better cleavage efficiency in contrast to the 2-nitrobenzyl
group.
During the next 90min of irradition no changes of the signals corrsponding to the formed
products could be observed, which indicates an optimum cleavage time of 30min.
However, no of the fractions corresponding to the signals at retention times of 14.9min,
12.3min, 6.3min, 4.8min or 4.1min could be identified as the nitroxide radical 65 or the
hydroxylamine species.
The results obtained from the cleavage reactions of the 2-nitrobenzyl and the DMNB
protected spin labels 66 and 67 show that these photolabile protection groups are not
suitable for the α-TOPP spin label, since the nitroxide radical could not be recovered
after irradiation.
Probably the spin label is not stable under the irradiation conditions and is decomposed
upon the cleavage of the protecting groups.
Taking these results into account, there was no point to incorporate these photolabile
protected spin labels into peptide fragments to test ligation reactions, because the removal
of the 2-nitrobenzyl and DMNB groups would probably also fail for peptide incorporated
spin labels.
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Figure 49: Monitoring of the DMNB deprotection reaction by RP-HPLC.
However, continuing the project without the usage of a nitroxide protecting group, would
lead to a peptide fragment containing a reduced nitroxide radical, since previous research
on the α-TOPP spin label revealed the reduction of the nitroxide radical under the final
cleavage conditions. Thereby, the reduction of the nitroxyl is caused by the reducing
agents TIS and EDT, which are important additives to prevent oxidative side-reactions
during the final peptide cleavage.
Since there are cysteine and tryptophane residues in the peptide fragment, the addition
of these reducing agents cannot be avoided. Otherwise, oxidation of the tryptophane
residues and disulfide bond formation between cysteine residues would readily occur.
Thus, an unmasked nitroxide radical in the peptide fragment would be converted into
the reduced hydroxylamine during final cleavage and could not be recovered back by
oxidation, without oxidizing the free thiol group of the cysteine residues.
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6 Summary and Outlook
The main aim of this work was to design and synthesize a β-turn inducing or stabilizing
spin label which could be directly incorporated into peptides by SPPS. Therefore, based
on the idea to stabilize or induce β-turn conformations in peptides by geometrical pre-
organization, an azabicyclo amino acid derived spin label was designed (Figure 50) and
suitable synthesis approaches were developed.
Figure 50: Design of the azabicyclo derived β-turn stabilized spin label.
In the course of this work, two retrosynthetical approaches for the synthesis of the β-turn
inducing spin label were developed and tested.
The first approach was based on the previously described synthesis[71] of the azabicyclo
amino acid and required the preparation of a carboxyl substituted γ-lactam spin label
(Figure 51).
Figure 51: Schematic representation of the synthesis of the new β-turn stabilizing spin label.
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The γ-lactam spin label was aimed to be synthesized from a dibromide spin label, whose
preparation was previously described.[77] Following the developed synthesis route, the
preparation of the desired γ-lactam spin label could not be completed successfully, since
the reductive cyanation of the cyclic imide failed probably due to decomposition of the
reactant under the applied reaction conditions.
Thus, a second approach for the synthesis of the azabicyclo spin label was developed and
tested, which utilized a stannyl anion mediated cyclization reaction to form the annealed
ring system of the target spin label (Figure 52).
Figure 52: Retrosynthetic design of the β-turn stabilizing spin label. The key step of the synthesis is an
intramolecular anionic cyclisation of an imide substituted spin label, that is synthesized from
a vinyl bromide spin label. The substituent x represents a suitable carboxyl precursor.
As a principle of proof, anionic cyclisation between a vinylbromide spin label and a cyclic
imide was performed successfully yielding the new bicyclic spin label, that lacked at this
stage of the synthesis a carboxyl moiety (Figure 53).
Figure 53: Synthesis of the azabicyclo spin label to test the anionic cyclisation reaction.
Therefore, synthetical strategies for the functionalization of the bicyclic spin label by a
carboxyl acid group were developed (Figure 54). The first approach A was based on the
usage of an amino nitrile spin label prepared by a Strecker reaction.
However, the approach revealed to be not suitable, since the attempted amino nitrile spin
label turned out to be not stabile and converted to the corresponding imine by HCN
elimination. Thus, the functionalization was continued using the second approach B.
For the second approach, the preparation of a cyanohydrin spin label was required. The
desired cyanohydrin spin label could be prepared from the aldehyde spin label but not be
isolated, due to fast conversion into the starting material.
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Figure 54: Attempted synthetic strategies for C-C bond formation. Routes A and B aim to introduce
a nitrile group as carboxyl acid precursor via Strecker or a cyanohydrin reaction. Route C
is based on the direct nucleophilic addition of the cyclic imide to the carbonyl C to form a
secondary alcohol.
Therefore, another approach C for the functionalization was tested, whereby a hydroxyl
group functionalized imide was successfully synthesized and utilized for the anionic cy-
clization reaction. However, the reactant was not tolerated by the cyclization reaction, so
that the synthesis of the target spin label could not be accomplished.
Thus, an easier accessible β-turn conformation stabilizing spin label for the SPPS us-
ing a completely different spin label design was synthesized.
The new design was inspired by azapeptides that are known to adopt different types of
β-turn conformations due to the conformationally constrained aza residue. In addition to
that, they can be easily modified by side-chain mimetics or different functinalities during
the azapeptide synthesis.[84−89] Thus, an azadipeptide based protected spin label was de-
veloped and could be successfully synthesized by alkylation of an azadipeptide monomer
(Figure 55). Furthermore, the nitroxyl protected spin labeled azadipeptide could be incor-
porated into a model peptide by SPPS leading to a new class of spin labled azapeptides
(Figure 55). However, at the current stage the removal of the nitroxyl protecting group
failed due to the incompatibility of the azapeptide with the conditions of its deprotec-
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Figure 55: Synthesized azadipeptide spin label (left) and the prepared azapeptide using the new methoxy
protected spin label (right).
tion. Nevertheless, the synthesized spin label could be a promising canditate for further
studies on the conformational effect of spin labeled aza residues in peptides in terms of
stabilization or induction of turn structures.
Therefore, in order to use the new nitroxide protected spin labeled azadipeptide in fur-
ther applications, a new protecting group strategy is required to recover the paramagnetic
nitroxyl group. Therefore, a photolabile protecting group such as 2-nitrobenzyl could be
applied.
In the course of this work, a photolabile protecting group approach for the synthesis
of α-TOPP spin labeled peptides by NCL should be established. The NCL is one of the
most used techniques to synthesize large proteins from two or more protein fragments
by a selective reaction between a C-terminal thiolester residue and a N-terminal thiol
residue.[6]
Since the semi-rigid α-TOPP spin label showed promising results in conformational EPR
studies of transmembrane model peptides[4], its application in larger protein systems is
highly desirable.
To incorporate the α-TOPP spin label into a cysteine containing peptide fragment by
SPPS, the nitroxide radical needs to be masked by a photolabile protecting group to
avoid side-reaction with the redox active cysteine residue. Moreover, photolabile protect-
ing groups for nitroxide radicals are suitable due to their compatibility with the Fmoc/tBu
protecting group strategy for SPPS and the easy recovery of the nitroxide radical by ir-
radiating the protected peptide with UV light.
For the synthesis of the 2-nitrobenzyl and DMNB protected α-TOPP spin labels, the
α-TOPP spin label was synthesized in nine steps according to previously published
procedures.[3,4] Thereby, the synthesis of the α-TOPP spin label could be optimized in
terms of time efficiency and usage of benign starting material for the preparation of the
cyclic imide. The Chan-Lam cross-coupling, that is crucial for the formation of the spin
label framework, could be successfully optimized by performing the reaction under oxy-
gen pressure. The change of this reaction parameter led to a reduction of the reaction
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time from 14 d to 3 d. In addition to that, the preparation of the cyclic imide could be
optimized by using more benign starting material and avoid time consuming purification
steps. Finally, the α-TOPP spin label was successfully protected by the 2-nitrobenzyl
and the DMNB photolabile groups (Figure 56). However, the 2-nitrobenzyl derived pho-
Figure 56: Synthesized 2-nitrobenzyl protected (left) and DMNB protected (right) α-TOPP spin label.
tolabile protecting groups turned out to be not suitable for the synthesis of α-TOPP
spin labeled peptides, which was revealed by preliminary deprotection studies of the 2-
nitrobenzyl and DMNB protected α-TOPP spin labels. For the complete removal of the
protection groups, the 2-nitrobenzyl protected spin label was irradiated for 2 h and the
DMNB protected spin label for 30min, which is quite long.
In addition to that, neither the nitroxide radical species nor the corresponding hydroxy-
lamine intermediate could be isolated after irradiation, which could indicate the instability
of the α-TOPP spin label under the applied cleavage conditions.
Therefore, for future attempts a coumarine based protecting group could be tested, which
might result in higher cleavage rates and be therefore, a suitable protection group.[97]
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7 Experimental Part
7.1 Materials and Methods
7.1.1 Reagents and Solvents
The reactions were performed using commercial available reagents without any further
purification that were provided by ABCR (Karlsruhe, Germany), ACROS ORGANICS (Geel,
Belgium), ALFA AESAR (Karlsruhe, Germany), BACHEM (Bubendorf, Switzerland), CARL
ROTH (Karlsruhe, Germany), FISCHER SCIENTIFIC (Nidderau, Germany), FLUKA (Tauf-
kirchen, Germany), MERCK (Darmstadt, Germany), RIEDEL-DE HAËN (Seelze, Germany),
TCI (Eschborn, Germany) and VWR (Darmstadt, Germany).
The Fmoc-protected amino acids, coupling reagents and the Rink amide MBHA resin
were purchased from GL BIOCHEM (Shanghai, China), IRIS (Marktredwitz, Germany),
ACROS ORGANICS (Geel, Belgium) and MERCK (Darmstadt, Germany).
Reactions under standard aerobic conditions were performed in p.a. grade solvents,
while reactions with oxygen or water sensitive components were performed in commer-
cially available extra-dry solvents. The solvents were obtained from SIGMA-ALDRICH
(Taufkirchen, Germany) and ACROS ORGANICS (Geel, Belgium). Solvents for HPLC
purification and analysis were purchased from FLUKA (Taufkirchen, Germany), VWR IN-
TERNATIONAL
(Fontenay-sous-Bois, France), ACROS ORGANICS (Geel, Belgium) and SIGMA-ALDRICH
(Taufkirchen, Germany). Ultra-pure water (MilliQ) was prepared from demineralised wa-
ter using the purification systems SYMPLICITY from MERCK MILLIPORE (Bedford, UK)
and arium R© mini from SATORIUS (Göttingen, Germany).
Deuterated chloroform (CDCl3) and dimethyl sulfoxide (DMSO-d6) for the NMR analysis
were obtained from DEUTERIO (Kastellaun, Germany).
7.1.2 Methods
Reactions
Reactions utilizing oxygen or water sensitive reagents or intermediates were carried out in
dried glassware under an argon or nitrogen atmosphere. To remove residual moisture and
air, the glass apparatus was heated in vacuo and was allowed to cool to room temperature,
before purging with argon or nitrogen. Thereby, this process was repeated three times.
All reagents were added to the apparatus either in a counter stream of argon or nitrogen
or through a septum via a syringe cannula.
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Lyophilization
The aqueous solution of the sample was frozen in liquid nitrogen and freeze-dried in high
vacuum. Thereby, fractions collected from RP-HPLC purification were concentrated in
a nitrogen stream to remove MeCN and TFA from the solution. For the lyophilization
a CHRIST ALPHA-2-4 lyophiliser (Osterode am Harz, Germany) equipped with a high
vacuum pump was employed. Samples containing a volume up to 1.5mL were freeze-dried
in microcentrifuge tubes in speedvac device RVC 2-18 CD plus of CHRIST (Osterode am
Harz, Germany) connected to the lyophiliser.
Thin Layer Chromatography
For analysis of samples by thin layer chromatography (TLC), silica coated aluminium-
backed TLC-plates (0.2µm, silica gel 60 F254) from MERCK (Darmstadt, Germany) were
used as stationary phase. After applying the sample on the bottom of the plate and devel-
oping the TLC-plate in the appropriate solvent mixture, the substances were visualized
on the plate by fluorescence quenching at 254 nm or by staining. Therefore, the plate
was immersed in a ninhydrin solution (3% ninhydrin in EtOH) and was subsequently
heated, whereby compounds containing amine groups appeared red on the TLC-plate.
The retention factor (Rf ) of a compound is defined as the ratio of the compound‘s front
distance to the solvent front distance.
Flash Column Chromatography
For purification of compounds flash column chromatography was performed by applying
pressure in a range from 0.1 to 0.8 bar. For the chromatography glass columns equipped
with a frit were used and filled with silica gel (Type 60, 40–63 nm, from MERCK (Darm-
stadt, Germany)) suspended in an appropriate solvent mixture.
High Performance Liquid Chromatography
High performance liquid chromatography (HPLC) was carried out on JASCO (Gross-
Umstadt, Germany) instruments equipped with an analytical reversed phase column
(Nucleodur R© RP C-18 analytical HPLC column, 250 nm x 4.6 mm, 5 µm) fromMACHEREY-
NAGEL (Düren, Germany) with a flow of 0.5mL/min. For the detection of the compounds,
UV absorptions at 215, 254 and 280 nm were utilized. For the elution of the compounds,
the solventA: bi-demineralised H2O+0.1%TFA and solventB: MeCN+0.1%TFA were
used, whereby a concentration gradient of solventB was applied, as defined in exper-
imental procedure. Reaction monitoring was performed on a JASCO system equipped
with a MD-2010plus multiwavelength detector, LC-Net II/ADC, CO-2060plus intelligent
column thermostat, AS-2055plus intelligent sampler and two PU-2085plus semi-micro
HPLC pumps. Peptides were purified on analytical scale using a JASCO system equipped
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with a MD-2010plus multiwavelength detector, LC-Net II/ADC, a DG-2080-53 3-line de-
gasser and two PU 2086plus intelligent HPLC pumps. The samples were dissolved in an
appropriate mixture of bi-demineralised water and MeCN followed by filtering using a
CHROMAFIL R© RC-45/15 MS filter from MACHERY-NAGEL.
7.2 Analysis
Nuclear Magnetic Resonance
Nuclear magnetic resonance NMR experiments for the characterisation of synthesized
compounds were performed on VARIAN (California, USA) instruments (Mercury (VX)
300, Unity 300, Inova-500). The sample temperature was set for CDCl3 to 298 K and for
DMSO-d6 to either 298K or 308K. The frequencies used in the measurements are given
in the analytic data section of the corresponding compound. The 13C-NMR experiments
were proton-decoupled and the chemical shift δ is indicated in part per million (ppm). The
chemical shift of the solvents was used as the internal standard with δ=7.26 ppm (1H)
and 77.16 ppm (13C) for CDCl3 and δ=2.50 ppm (1H) and 39.52 ppm (13C) for DMSO-
d6. The following abbreviation for the multiplicities of the signals were used: s= singlet,
d=doublet, t= triplet, q=quartet, hept=heptet, m=multiplet and sbr=broadened sin-
glet. The coupling constant nJx,y was calculated using the measuring frequency in Hertz,
whereby n is the number of the bonds between the coupling nuclei and x and y represent
the coupling nuclei.
Mass Spectrometry
For the analysis of the compounds, mass spectrometry was performed using the ionisa-
tion technique electrospray ionisation (ESI). The data obtained from the mass spectrum
was in mass-to-charge ratio (m/z). The ESI and high resolution ESI (HR-ESI) measure-
ments were performed using either a BRUKER (Massachusetts, USA) micrOTOF-Q II or
a BRUKER maXis ESI-QTOF-MS instrument.
UV/Vis Spectroscopy
The concentration of peptide solutions were calculated according to the absorption of the




Thereby, A is defined as the measured absorption at 280 nm, ε as the molar extinction
coefficient in cm−1M−1 and d as the path length in cm. Reference spectra were obtained
from pure solvents. The UV/vis measurements were performed on a V-650 JASCO spec-
trometer equipped with a JASCO temperature controller ETCS-761 and a thermostat
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from JULABO F250 (Seelbach, Germany) in glass cuvettes Suprasil R© (QS) from HELLMA
(Müllheim, Germany).
Circular Dichroism Spectroscopy
For the analysis of the secondary structure in peptide, circular dichroism (CD) spec-
troscopy was applied using a JASCO J-1500 spectropolarimeter equipped with a cell holder
and an installed peltier thermostat JASCO PTC-510 connected to a JULABO F250 ther-
mostat. Before and during the measurement, the device was purged with nitrogen. The
measurement of the 50µmol solution of the peptide in MeOH was performed in 1.0mm
quartz glass cuvette from HELLMA (Suprasil R© QS) and the temperature during the mea-
surement was controlled by the sensor in the holder. For the CD measurement, a measure-
ment range from 260-190 nm, a data pitch of 0.1 nm, the CD scale of 200/0.1mdeg/dOD,
the FL scale of 200/0.1mdeg/dOD, a digital integration time (D.I.T) of 1 s, a bandwidth
of 1 nm, a scanning speed of 50 nm/min and accumulation number of 10 were applied.
The measurement of the pure solvent served as reference. The CD signal was obtained as
the relative ellipticity Θ in mdeg, which was converted into the molar ellipticity ΘM in
deg · cm2 · dmol−1 using the following equation:
ΘM =
Θ
100 · c · d (2)
Thereby, Θ is the elipticity in mdeg, c is the peptide concentration in mol/L and d is the
path length in cm.
7.3 Standard Operating Procedures
7.3.1 Ninhydrin Color Test
The ninhydrin color test[99] is a method to detect free primary amine groups in resin bound
peptide and is performed to monitor N-terminal Fmoc deprotection and attachement
of amino acid residues. Therefore, 2-3 drops of solution I (5 g ninhydrin dissolved in
100mL EtOH), solution II (80 g phenol dissolved in 20mL EtOH) and solution III (2mL
of an aqueous KCN solution (1·10−3 M) in 98mL pyridine) were added to few peptidyl
resin beads in a 1mL glass vessel and the suspension was warmed on a heating plate to
approximately 120 ◦C. Thereby, in case of free primary amino groups, the color of the
solution and the resin beads turns blue, as a result of an reaction between the in-situ
generated ninhydrin reagent and the amine group. The solution and the resin beads
remain yellow to colorless in the case of a negative result.
7.3.2 Manual Solid-Phase Peptide Synthesis
The manual synthesis of side-chain protected peptides according to the Fmoc/tBu strategy
was performed microwave (CEM Discover, Kamp-Lintfort, Germany) assisted applying
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the following parameters and settings for the double deprotection and coupling steps:
Process Monomer Parameters
Deprotection 50 ◦C, 30 s, 25W
(Two-Stage Deprotection) 50 ◦C, 180 s, 25W
Coupling Fmoc-AA-OH 50 ◦C, 3min, 10W
(Double Coupling)
Thereby, the SPPS was performed on a Fmoc protected low loaded Rink amide MBHA
resin with a loading capacity of 0.36mmol/g on the scale, as stated in experimental





Before synthesis, the Rink amide MBHA resin was placed in a syringe (BD Discardit II)
equipped with a stopper and an polyethylene frit. Then, DMF was added until the resin
was covered by the solvent and the resin was swollen for 30min at room temperature by
agitating on an automated shaker. Afterwards, the solvent was discarded and the syn-
thesis started with the removal of the Fmoc protection group from the Rink amide resin
using a 20 vol% deprotection solution of piperidine in DMF.
Thereby, a two-stage deprotection was performed applying the microwave settings from
the table above by adding the deprotection solution to the resin until it was covered by
the solvent. Between the first and the second stage of deprotection, the resin was washed
with DMF three times. After the deprotection of the Fmoc group, the resin was washed
with DMF, DCM and DMF three times each and the first amino acid was attached sub-
sequently to the resin in the next step.
Therefore, the carboxyl group of the Fmoc protected amino acid was activated by the ac-
tivating agents HOAt and HATU, 4 and 3.9 equivalents each, in DMF upon addition of 4
equivalents of the activator base DIPEA. The Fmoc protected amino acid (Fmoc-AA-OH)
was dissolved in the activator solution and transfered to the swollen resin, followed by the
addition of the activator base. After irradiating the resin in the coupling solution, using
the settings defined in table above, the resin was washed with DMF, DCM and DMF three
times each. The coupling step was performed twice for each amino acid to ensure good
coupling efficiency. For the attachement of the next amino acid residue, double deprotec-
tion was performed to cleave the Fmoc group from the N-terminus and subsequently the
double coupling of the next amino acid was performed. This deprotection-coupling cycle
was repeated until the desired sequence was synthesized.
Finally, the N-terminal Fmoc protection group was removed and capping of the termi-
nal amino group was performed. Therefore, a freshly prepared solution of 20 vol% acetic
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anhydride in DMF was added to the peptidyl resin and the mixture was agitated on an
automated shaker for 5min at room temperature. Afterwards, the peptidyl resin was
washed with DMF, DCM and MeOH three times each and dried in vacuo.
7.3.3 Final Peptide Cleavage and Work-Up
For the cleavage of the peptide from the resin and removal of the side-chain protection
groups, the peptidyl resin was agitated for 2 h at room temperature in a cleavage cocktail
containing 2.5 vol% TIS and 2.5 vol% H2O in TFA. Afterwards, the filtrate was collected
and the TFA was removed in a nitrogen stream. The residue was suspended in cold diethyl
ether and the resulting suspension was centrifugated to yield a pellet of the precipitated
peptide after decanting of the supernatant. Then, the peptide was resuspended in cold
diethyl ether, centrifugated and the supernatant was discarded to wash the crude peptide.
The washing procedure was repeated three times and afterwards, the crude peptide was
dried under reduced pressure.
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7.4 Synthesis of β-Turn inducing Spin Label
3,5-Dibromo-2,2,6,6-tetramethylpiperidinium bromide (2) [72]
A solution of Br2 (0.50mL, 1.54 g, 19.3mmol, 2.00 eq) in glacial AcOH (10mL) was added
dropwise to a pre-cooled solution of 2,2,6,6-tetramethyl-4-piperidone (1.50 g, 9.66mmol,
1.00 eq) in glacial AcOH (20mL) at 0 ◦C. After complete addition the mixture was allowed
to warm up to room temperature and was stirred for 18 h. The precipitated hydrobromide
salt 2 was filtered and washed with glacial AcOH (2 x 50mL) and Et2O (2 x 50mL). The
hydrobromide salt (mixture as diastereomers) 2 was obtained after drying in vacuum as
colorless solid (2.21 g, 8.11mmol, 84% ).
1H-NMR (300MHz, DMSO-d6): δ [ppm]=9.68 (s, 2H, 2 xNH2+), 5.58 (s, 2H, 2 xCH),
5.48 (s, 2H, 2 xCH), 1.72-1.65 (m, 12H, 4 xCH3), 1.50-1.41 (m, 12H, 4 xCH3).
Methyl-2,2,5,5-tetramethyl-2,5-dihydropyrrole-3-carboxylate (3) [72]
A NaOMe solution in MeOH (2.4M, 9.53mL, 22.9mmol, 3.00 eq) was added to pre-cooled
dry MeOH (10mL) under an argon atmosphere. Then, the hydrobromide salt (2) (3.04 g,
7.62mmol, 1.00 eq) was added in portions to the NaOMe solution and the reaction was
stirred at room temperature for 2 h. The solvent was removed under reduced pressure
and the residue was dissolved in Et2O (30mL), washed with 5% aq. NaHCO3 solution
(2 x 20mL) and the combined aqueous fractions were extracted with Et2O (2 x 20mL). Af-
ter drying the combined organic fraction over MgSO4 the solvent was removed under high
pressure. Finally, the methyl ester 3 was obtained after purification with flash column
chromatography on SiO2 (Pe/EtOAc, 60/40, v/v) as a yellowish oil (1.03 g, 5.63mmol,
74%).
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ESI-MS: m/z =184.1 [M+H]+.
ESI-HRMS: m/z calcd. for C10H17N1O2H [M+H]+: 184.1332 found: 184.1335.
Methyl-2,2,5,5-tetramethyl-2,5-dihydropyrrole-3-carboxylate-1-oxyl (4) [72]
The amine 3 (2.50 g, 13.6mmol, 1.00 eq) was dissolved in dry Et2O (50mL) under an
argon atmosphere and the solution was cooled to 0 ◦C. Then, a solution of m-CPBA
(77w%, 6.15 g, 27.3mmol, 2.00 eq) in dry Et2O (40mL) was added dropwise and the re-
action mixture was stirred at 0 ◦C for 2 h. Afterwards, 10% aq. Na2CO3 solution (50mL)
was added and the mixture was extracted with Et2O (3 x 50mL). The combined organic
fractions were dried over MgSO4 and the solvent was removed in vacuo. The purification
of the crude product by flash column chromatography on SiO2 (Pe/EtOAc, 70/30, v/v)
yielded the desired nitroxide 4 as a yellow solid (2.32 g, 11.7mmol, 86%).
ESI-MS: m/z =199.1 [M+H]+, 221.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C11H19N1O3H [M+H]+: 199.1203 found: 199.1196, calcd.
for C11H19N1O3Na [M+Na]+: 221.1022 found: 221.1020.
trans-3-Methoxycarbonyl-2,2,5,5-tetramethyl-4-nitromethyl-pyrrolidin-1-oxyl (5) [74]
The methyl ester 4 (2.00 g, 10.0mmol, 1.00 eq) and nitromethane (1.07mL, 1.22 g,
20.0mmol, 2.00 eq) were dissolved under an argon atmosphere in dry MeCN (20mL).
Then, DBU (1.49mL, 1.52 g, 10.0mmol, 1.00 eq) was added and the reaction solution was
stirred at 55 ◦C for 24 h. Afterwards, the solution was dilluted by the addition of CHCl3
(20mL) and the resulting solution was washed with 3% aq. H2SO4 (3 x 20mL) and with
saturated aq. NaCl solution (3 x 20mL). The organic layer was dried over MgSO4 and the
solvent was removed in vacuum. Finally, the crude product was purified by flash column
chromatography on SiO2 (Pe/EtOAc, 70/30, v/v) to yield the desired nitroxide 5 as a
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yellow solid (1.74 g, 6.70mmol, 67%).
ESI-MS: m/z =260.1 [M+H]+, 225.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C11H19N2O5H [M+H]+: 260.1367 found: 260.1365, calcd.
for C11H19N2O5Na [M+Na]+: 282.1186 found: 282.1183.
trans-4-Formyl-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidin-1-yloxyl Radical
(6) [73]
A solution of the γ-nitro methyl ester 5 (2.00 g, 7.72mmol, 1.00 eq) in MeOH (40mL) was
cooled to 0 ◦C and subsequently a solution of KOH (540mg, 9.65mmol, 1.25 eq) in MeOH
(100mL) was added dropwise. After completion of the addition, the mixture was stirred
at 0 ◦C for further 15min and then a solution of KMnO4 (850mg, 5.33mmol, 0.74 eq) and
MgSO4 (927 g, 7.72mmol, 1.00 eq) in H2O (100mL) was added. Afterwards, the mixture
was stirred 0 ◦C for 1.5 h, filtered through a pad of celite and the filtrate cake was washed
thoroughly with CHCl3 (70mL). After separation of the organic phase, the aqueous phase
was extracted with CHCl3 (3 x 50 mL) and the combined organic phase was dried over
MgSO4. After removal of the solvent in vacuo, the residue was purified by flash column
chromatography on SiO2 (Pe/EtOAc, 60/40, v/v) to yield the desired aldehyde nitroxide
6 as a yellow solid (653mg, 2.86mmol, 37%).
ESI-MS: m/z =228.1 [M].
ESI-HRMS: m/z calcd. for C11H18N1O4 [M]: 228.1230 found: 228.1234.
trans-3,4-Bis(hydroxymethyl)-2,2,5,5-tetramethylpyrrolidin-1-yloxyl Radical (7) [73]
The aldehyde methyl ester 6 (2.00 g, 8.75mmol, 1.00 eq) was dissolved in EtOH (30mL)
and NaBH4 (1.00 g, 26.5mmol, 3.00 eq) was added in portions at 0 ◦C. After the addi-
tion was completed, the mixture was allowed to stand at room temperature for 45min.
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Then, the solvent was removed under high pressure and the residue was dissolved in
saturated aq. NH4Cl solution (20mL). The reaction solution was extracted with CHCl3
(3 x 20mL) and the combined organic layers were dried over MgSO4. After removal of
the solvent in vacuo, the residue was purified by flash column chromatography on SiO2
(Pe/EtOAc, 50/50, v/v). The desired 1,4-diol nitroxide 7 was obtained as yellow solid
(1.27 g, 6.30mmol, 72%).
ESI-MS: m/z =203.2 [M+H]+, 225.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C10H20N1O3H [M+H]+: 203.1516 found: 203.1510, calcd.
for C10H20N1O3Na [M+Na]+: 225.1335 found: 225.1334.
trans-3,4-Bis(iodomethyl)-2,2,5,5-tetramethylpyrrolidin-1-yloxyl Radical (8) [73]
A solution of 1,4-diol 7 (2.00 g, 10.0mmol, 1.00 eq) and Et3N (3.01mL, 2.20 g, 22.0mmol,
2.20 eq) in DCM (70 mL) was pre-cooled to 0 ◦C under an argon atmosphere. Then, MsCl
(1.69mL, 2.50 g, 22.0mmol, 2.20 eq) was added dropwise to the solution at 0 ◦C and the
reaction mixture was stirred at room temperature for 1 h. Afterwards, the mixture was
washed with saturated aq. NaCl solution (40mL) and the organic layer was dried over
MgSO4. After removal of the solvent under reduced pressure the bis(mesylate) interme-
diate was immediately dissolved in dry THF (60mL) and upon addition of NaI (7.50 g,
50.0mmol, 5.00 eq) the mixture was stirred at 75 ◦C for 34 h. The mixture was diluted
with Et2O (50mL) and the organic layer was washed with 10% aq. Na2S2O3 solution
(50mL) and saturated aq. NaCl solution (3 x 30mL). After drying the organic layer over
MgSO4 and removing the solvent under reduced pressure, the residue was purified by
flash column chromatography on SiO2 (Pe/EtOAc, 60/40, v/v) to yield the diiodide 8 as
a yellow solid (2.36 g, 5.60mmol, 56%).
ESI-MS: m/z =423.0 [M+H]+, 444.9 [M+Na]+.
ESI-HRMS: m/z calcd. for C10H18N1O1I2H [M+H]+: 422.9551 found: 422.9559, calcd.
for C10H18N1O1I2Na [M+Na]+: 444.9370 found: 444.9378.
3,4-Bis(methylene)-2,2,5,5-tetramethylpyrrolidin-1-yloxyl Radical (9) [73]
The diiodide 9 (1.00 g, 2.37mmol, 1.00 eq) was dissolved in EtOH (15 mL) and a 10%
aq. NaOH solution (5mL) was added. Then the reaction mixture was stirred at 80 ◦C for
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40min. Afterwards, the solvent was removed in vacuo and the aqueous solution was ex-
tracted with Et2O (2 x 20 mL). The organic phase was dried over MgSO4 and the solvent
was removed under reduced pressure. Finally, purification of the residue by flash column
chromatography on SiO2 (Pe/EtOAc, 60/40, v/v) gave the desired diene nitroxide 9 as
an orange solid (316mg, 1.90mmol, 80%).
ESI-MS: m/z =167.1 [M+H]+, 189.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C10H16N1O1H [M+H]+: 167.1305 found: 167.1297, calcd.
for C10H16N1O1Na [M+Na]+: 189.1124 found: 189.1122.
3,4-Bis(dibromomethyl)-2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-yloxyl Radical
(10) [73]
To reduce the nitroxide radical the diene nitroxide 9 (500mg, 3.00mmol, 1.00 eq) was dis-
solved in a 2.4M ethanolic HCl solution (6mL) and stirred at 80 ◦C for 1 h. Afterwards,
the solvent was removed under reduced pressure to give the colorless hydroxylamine in-
termediate that was immediately dissolved in CHCl3 (20mL). Then, a solution of Br2
(0.32mL, 1.00 g, 6.00mmol, 2.00 eq) dissolved in CHCl3 (3mL) was added dropwise and
the reaction mixture was stirred at 65 ◦C for 30min. Afterwards, the solution was al-
lowed to warm up to room temperature and a solution of NaNO2 (415mg, 6.00mmol,
2.00 eq) in H2O (5mL) was added dropwise to oxidize the hydroxylamine to the nitroxide
radical. After the addition was completed, the mixture was stirred for 20min at room
temperature. Then, the organic layer was separated, washed with 10% aq. Na2S2O3
solution (20mL) and dried over MgSO4. The solvent was removed under reduced pres-
sure and the residue was purified by flash column chromatography on SiO2 (Pe/EtOAc,
60/40, v/v) to give the dibromide nitroxide 10 as a yellow solid (518mg, 1.59mmol, 53%).
ESI-MS: m/z =325.0 [M+H]+, 347.0 [M+Na]+.
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ESI-HRMS: m/z calcd. for C10H16N1O1Br2H [M+H]+: 324.9671 found: 324.9676,




Benzylamine (0.15mL, 148mg, 1.38mmol, 0.90 eq) and K2CO3 (423mg, 3.06mmol, 2.00 eq)
were added to a solution of dibromide nitroxide 10 (500mg, 1.53mmol, 1.00 eq) in MeCN
(10mL) and the reaction mixture was stirred at 80 ◦C for 20 h. Afterwards, the mixture
was filtered and the solvent was removed under reduced pressure. The residue was dis-
solved in DCM (20mL), washed with water (2 x 20mL) and the combined aqueous phases
were extracted with DCM (3 x 20mL). Then the combined organic phase was dried over
MgSO4 and the solvent was removed under reduced pressure. Finally, the purification of
the crude product by flash column chromatography on SiO2 (DCM/MeOH, 98/2, v/v)
yield the bicyclic nitroxide 11 as a brown solid (166mg, 0.61mmol, 40%).
ESI-MS: m/z =272.2 [M+H]+, 294.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C17H23N2O2H [M+H]+: 272.1883 found: 272.1885, calcd.




Cyclic amine nitroxide 11 (200mg, 0.74mmol, 1.00 eq) and Na2CO3 (0.74 g, 7.00mmol,
10.0 eq) were dissolved in THF/H2O (v/v, 2.5/1, 5mL) and iodine (667mg, 5.25mmol,
7.50 eq) was added to the solution. Then, the reaction mixture was stirred at room
temperature for 14 h and a saturated aq. Na2S2O4 solution (1mL) and subsequently a
saturated aq. Na2CO3 solution (1mL) were added to the reaction solution. Afterwards,
the reaction solution was extracted with DCM (3 x 10mL) and the combined organic lay-
ers were dried over MgSO4. After removal of the solvent in vacuo, the residue was purified
by flash column chromatography on SiO2 (DCM/MeOH, 98/2, v/v) to give the imide ni-
troxide 12 as a brown oil (92.8mg, 0.31mmol, 42%).
ESI-MS: m/z =210.1 [M+H]+.
ESI-HRMS: m/z calcd. for C10H13N2O3H [M+H]+: 210.0999 found: 210.1266.
(3-Carboxy-4-bromo-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yl)oxidanyl
Radical (16)[76]
Bromine (5.27mL, 16.4 g, 206mmol, 3.50 eq) was added slowly to a precooled solution
(0 ◦C) of NaOH (39.2 g, 980mmol, 16.7 eq) in H2O (300mL) and the resulting NaOBr so-
lution was stirred at 0 ◦C for 20min. Then, the NaOBr solution was cooled to −5 ◦C and
a solution of 4-Oxo-TEMPO 1 (10.0 g, 58.7mmol, 1.00 eq) and NaOH (9.80 g, 245mmol,
4.17 eq) in 1,4-dioxane/H2O (v/v, 4/1, 250mL) was added dropwise. After the addition
was complete, the reaction solution was stirred for additional 30min at room temperature.
The insolubilities were filtered off and the filtrate was acidified by concentrated HCl to
a pH of 2. The precipitated yellowish solid was filtered off and washed thoroughly with
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cold water (20mL) and Et2O (3 x 50mL). The desired carboxy nitroxide 16 was obtained
after drying in vacuo as a light yellow solid (3.55 g, 13.5mmol, 23%).
ESI-MS: m/z =262.0 [M], 285.0 [M+Na]+.
ESI-HRMS: m/z calcd. for C9H13NO3Br [M]: 262.0073 found: 262.0075, calcd. for
C9H13NO3BrNa [M+Na]+: 284.9971 found: 284.9972.
(3-Hydroxymethyl-4-bromo-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yl)oxidanyl
Radical (17)[77]
To a solution of carboxyl nitroxide 16 (600mg, 2.28mmol, 1.00 eq) and Et3N (0.40mL,
288mg, 2.85mmol, 1.25 eq) in dry Et2O (30mL) was added slowly ethyl chloroformate
(0.25mL, 285mg, 2.62mmol, 1.15 eq) at 0 ◦C. The reaction mixture was stirred at 0 ◦C
for 2 h. The precipitated salts were filtered off and the filtrate was concentrated under
reduced pressure. Then the residue was dissolved in dry THF (10mL) and the reaction
mixture was cooled to 0 ◦C. NaBH4 (95.0mg, 2.51mmol, 1.10 eq) and EtOH (0.5mL) were
added and the reaction was stirred at 0 ◦C for 2 h. The reaction mixture was quenched
with saturated aq. NH4Cl solution (10mL) and extracted with CHCl3 (3 x 20 mL). The
combined organic phase was dried over MgSO4 and the solvent was removed under reduced
pressure. The residue was purified by flash column chromatography on SiO2 (Pe/EtOAc,
60/40, v/v) to give the hydroxyl nitroxide 17 as a yellow solid (415mg, 1.66mmol, 73%).
ESI-MS: m/z =249.0 [M+H]+, 271.0 [M+Na]+.
ESI-HRMS: m/z calcd. for C9H15N1O2BrH [M+H]+: 249.0359 found: 249.0354, calcd.
for C9H15N1O2BrNa [M+Na]+: 271.0178 found: 271.0178.
3-Bromomethyl-4-bromo-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yl)oxidanyl
Radical (18)[77]
To a solution of alcohol 17 (500mg, 2.01mmol, 1.10 eq) and Et3N (0.31mL, 224mg,
2.21mmol, 1.10 eq) in DCM (10mL) was added dropwise a solution of MsCl (252mg,
2.21mmol, 1.10 eq) in DCM (5 mL) at 0 ◦C and the reaction mixture was stirred for
2 h. Then, the reaction mixture was washed with H2O (10mL) and the organic layer
was separated, dried over MgSO4 and the solvent was removed under reduced pressure.
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The intermediate was immediately dissolved in dry acetone (20mL) and upon addition
of LiBr (350mg, 4.02mmol, 2.00 eq) the mixture was stirred at 80 ◦C for 1 h. Afterwards,
the solvent was removed in vacuo and the residue was partitioned between H2O (10mL)
and EtOAc (20mL). The organic layer was separated and the aqueous layer was extracted
with EtOAc (3 x 10mL). The combined organic layer was dried over MgSO4 and the sol-
vent was removed under reduced pressure. The residue was purified by flash column
chromatography on SiO2 (Pe/EtOAc, 70/30, v/v) to give the bromide nitroxide 18 as an
orange solid (0.34 g, 1.09mmol, 54%).
ESI-MS: m/z =311.9 [M+H]+.
ESI-HRMS: m/z calcd. for C9H16N1O1Br2 [M+H]+: 311.9593 found: 311.9586.
tert-Butyl-(S)-(2,6-dioxopiperidin-3-yl)carbamate (20)[79]
To a solution of Boc-Gln-OH (2.00 g, 8.13mmol, 1.00 eq) in THF (45mL) was added CDI
(1.59 g, 9.76mmol, 1.20 eq) and a few crystalls of 4-(dimethylamino)pyridine. Afterwards,
the reaction was stirred at 70 ◦C for 18 h. Then, the solvent was removed under reduced
pressure and EtOAc (150mL) was added to the residue. After washing the organic layer
with H2O (50mL) and saturated aq. NaCl solution (50mL) the organic layer was dried
over MgSO4. The solvent was removed in vacuo and the crude product was purified by
flash column chromatography on SiO2 (DCM/MeOH, 95/5, v/v) to give the imide 20 as
a colorless solid (1.21 g, 5.28mmol, 65%).
1H-NMR (300MHz, CDCl3): δ [ppm]=7.171 (s, 1H, NH), 5.37 (s, 1H), 4.33 - 4.28 (m,
1H), 2.78 - 2.75 (m, 1H), 2.73 - 2.76 (m, 1H), 2.54 - 2.49 (m, 1H), 1.90 - 1.84 (m, 1H), 1.46
(s, 9H, 3 xCH3).
ESI-MS: m/z =251.1 [M+Na]+.





The cyclic imide 20 (248mg, 1.06mmol, 1.10 eq) and K2CO3 (146mg, 1.06mmol, 1.10 eq)
were added to a solution of bromide nitroxide 18 (300mg, 0.96mmol, 1.00 eq) in DMF
(10mL) and the reaction mixture was stirred at 90 ◦C for 2 h. Afterwards, the mixture was
filtered and the solvent was removed under reduced pressure. The residue was dissolved
in DCM (20mL), washed with water (2 x 20mL) and the combined aqueous phases were
extracted with DCM (3 x 20mL). Then the combined organic phase was dried over MgSO4
and the solvent was removed under reduced pressure. The crude imide nitroxide 21 was
obtained as a brown solid (166mg, 0.61mmol) and was used without further purification
in the next step.
ESI-MS: m/z =459.1 [M+H]+, 481.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C19H29N3O5BrH [M+H]+: 459.1363 found: 459.1357,




The imide radical 21 (0.31 g, 0.67mmol, 1.00 eq) was dissolved in DMF (5mL) and the
solution was precooled to 0 ◦C. Then, Bu3SnSiMe3 (0.45mL, 0.47 g, 1.29mmol, 1.92 eq)
and CsF (196mg, 1.29mmol, 1.92 eq) were added and the reaction solution was stirred
at room temperature for 21 h. Afterwards, H2O (5mL) and EtOAc (5mL) were added to
the reaction solution and the organic layer was separated and washed with saturated aq.
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NaCl solution (3 x 10mL). After removal of the solvent in vacuo, the residue was purified
by flash column chromatography on SiO2 (DCM/MeOH, 98/2, v/v) to give the azabicyclo
nitroxide 22 as a brown oil (105mg, 0.29mmol, 43%).
ESI-MS: m/z =363.2 [M+H]+, 385.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C19H28N3O4H [M+H]+: 363.2153 found: 363.2139,
calcd. for C19H28N3O4Na [M+Na]+: 385.1972 found: 385.1967.
4-Bromo-3-formyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-1-yloxyl Radical (23)
Activated MnO2 (1.00 g, 11.5mmol, 14.4 eq) was added to a solution of the alcohol 17
(200mg, 0.80mmol, 1.00 eq) in CHCl3 (20mL) and the mixture was stirred at 70 ◦C for
4 h. Then, the insolubilities were filtered off and the solvent was removed under reduced
pressure. The residue was purified by flash column chromatography on SiO2 (Pe/EtOAc,
60/40, v/v) to give the aldehyde nitroxide 23 as a yellow solid (162mg, 0.59mmol, 74%).
ESI-MS: m/z =269.0 [M+Na]+.




To a solution of the aldehyde nitroxide 23 (100mg, 0.40mmol, 1.00 eq) in MeOH (5mL)
NaCN (21.8mg, 0.44mmol, 1.10 eq), NaHSO3 (45.8mg, 0.44mmol, 1.10 eq) and AcOH
(25.2µL, 0.44mmol, 1.10 eq) were added at 0 ◦C and the mixture was stirred under an
argon atmosphere at room temperature for 20 h. Then the solvent was removed under
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reduced pressure and the residue was redissolved in DCM (5mL). The organic phase
was washed with saturated aq. NaCl solution (3 x 5mL) and the solvent was removed
in vacuo. The crude cyanohydrin nitroxide was was obtained as a orange oil (44mg,
0.16mmol, 41%) and was used due to fast decomposition without further purification.
ESI-MS: m/z =275.0 [M+H]+.




To a solution of the aldehyde nitroxide 23 (27.3mg, 0.41mmol, 1.00 eq) in MeCN (1mL)
the imide 20 (25.3mg, 0.41mmol, 1.00 eq) and DBU (18.2µL, 0.45mmol, 1.10 eq) were
added and the mixture was stirred at room temperature for 18 h. Then the solvent was
removed under reduced pressure and the residue was redissolved in EtOAc (5mL). The
organic phase was washed with saturated aq. NaCl solution (3 x 10mL) and the solvent
was removed in vacuo. After purification of the residue by flash column chromatography
on SiO2 (Pe/EtOAc, 70/30, v/v) the imide nitroxide 30 was obtained as a orange solid
(95mg, 0.20mmol, 48%).
ESI-MS: m/z =475.1 [M+H]+, 497.1 [M+Na]+, 492.2 [M+NH4]+.
ESI-HRMS: m/z calcd. for C19H29N3O6BrH [M+H]+: 475.1312 found: 475.1323,
calcd. for C19H29N3O6BrNa [M+Na]+: 497.1132 found: 497.1131,
calcd. for C19H29N3O6BrN1H4 [M+NH4]+: 492.1578 found: 492.1572.
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7.5 Synthesis of Spin Labeled Azapeptide
Benzhydrylidene Protected azaGly-Peptide Resin (34)
To a precooled solution of benzophenone hydrazone (19.7mg, 0.10mmol, 3.00 eq) in DCM
(0.5mL) a solution of p-nitrophenyl chloroformate (20.8mg, 102µmol, 3.20 eq) in DCM
(1mL) was added dropwise under an argon atmosphere and the reaction solution was
stirred for 2 h at 0 ◦C. Then, upon slowly addition of DIPEA (35.0µL, 0.20mmol,
6.00 eq) over 20min at 0 ◦C the mixture was immedeately transferred to the H-Gly-Gly-
Gly-Trp(Boc)-Lys(Boc)-Rink amide resin in DCM (1mL). The latter was previously pre-
pared according to the standard operation procedure 7.3.2 on a scale of 0.1mmol using a
Rink amide MBHA resin with a loading capacity of 0.36mmol/g, whereby the N-terminal
Fmoc protection group was cleaved. The peptidyl resin was agitated in the solution of the
preactivated benzophenone hydrazone intermediate at room temperature for 18 h. After-
wards, the azapeptidyl resin was filtered and washed subsequently with DMF (5 x 2mL),
MeOH (5 x 2mL) and DCM (5 x 2mL). After drying the azapeptidyl resin in vacuo, test-
cleavage was performed by subjecting a small amount of the peptidyl resin to a mixture
of TFA/TIS/H2O (v/v/v, 95/2.5/2.5, 1mL) and the cleavage was performed according to
the standard operating procedure 7.3.3.
ESI-MS: m/z =725.3 [M+H]+, 747.3 [M+Na]+, 769.3 [M+H+CO2]+.
ESI-HRMS: m/z calcd. for C37H44N10O6H [M+H]+: 725.3518 found: 725.3512, calcd.
for C37H44N10O6Na [M+Na]+: 747.3338 found: 747.3337, calcd. for C37H44N10O6C1O2H
[M+H+CO2]+: 769.3416 found: 769.3409.
Alkylation of Benzhydrylidene Protected azaGly-Peptide Resin (35)
The benzhydrylidene-azaGly-Gly-Gly-Gly-Trp(Boc)-Lys(Boc)-resin 34 (0.1mmol, 1.00 eq)
was swollen for 30min in THF (2mL). Then, a 40% aq. TEAH solution (64.7µL,
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0.1mmol, 3.00 eq) in THF (0.1mL) was added to the peptidyl resin and the mixture
was agitated for 30min at room temperature. Afterwards, the bromide nitroxide 18
(62.4mg, 0.2mmol, 2.00 eq) dissolved in THF (0.2mL) was added to the mixture and
the peptidyl resin was agitated in the alkylation solution at room temperature for 20 h.
The azapeptidyl resin was filtered and washed subsequently with THF (5 x 2mL), MeOH
(5 x 2mL) and DCM (5 x 2mL). After drying the alkylated azapeptidyl resin 35 in vacuo,
test-cleavage was performed by subjecting a small amount of the peptidyl resin to a
mixture of TFA/TIS/H2O (v/v/v, 95/2.5/2.5, 1mL) and the cleavage was performed ac-
cording to the standard operating procedure 7.3.3.
ESI-MS: m/z =485.7 [M+2H]2+, 970.4 [M+H]+, 1014.4 [M+H+CO2]+.
ESI-HRMS: m/z calcd. for C47H60Br1N11O7H [M+H]+: 970.3933 found: 970.3923,
calcd. for C47H60Br1N11O7H2 [M+2H]2+: 485.7003 Found: 485.7000,
calcd. for C47H60Br1N11O7C1O2H [M+H+CO2]+: 1014.3832 found: 1014.3818.
3-Bromo-4-(bromomethyl)-1-methoxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole
(40)[98]
To a solution of bromide nitroxide 18 (90.3mg, 0.29mmol, 1.00 eq) in DMSO (3mL)
FeSO4·7H2O (201mg, 0.73mmol, 2.50 eq) was added at 10 ◦C and subsequently a 35%
aq H2O2 solution (150µL, 1.45mmol, 5.00 eq) was added dropwise over 30min. After the
addition was complete, the reaction mixture was stirred for further 30min at 15 ◦C. Then
H2O (3mL) was added to the solution, the aqueous layer extracted with Et2O (3 x 5mL),
dried over MgSO4 and the solvent was removed in vacuo. The residue was purified by
flash column chromatography on SiO2 (Pe/EtOAc, 90/10, v/v) to give the methoxy pro-
tected nitroxide 40 as a clear oil (82.5mg, 0.25mmol, 87%).
ESI-MS: m/z =328.0 [M+H]+.




To a precooled solution of benzophenone hydrazone (703mg, 3.57mmol, 3.00 eq) in DCM
(2mL) was added dropwise a solution of p-nitrophenyl chloroformate (777mg, 3.81mmol,
3.20 eq) in DCM (1mL) under an argon atmosphere and the reaction solution was stirred
for 2 h at 0 ◦C. Then, upon slowly addition of DIPEA (1.25mL, 7.14mmol, 6.00 eq) over
20min at 0 ◦C the mixture was immedeately added to H-Gly-OtBu hydrochloride (200mg,
1.19mmol, 1.00 eq) in DCM (5mL) and the reaction solution was stirred at room temper-
ature for 16 h. The solvent was removed in vacuo and the residue was purified by flash
column chromatography on SiO2 (DCM/MeOH, 95/5, v/v) to give the benzhydrylidene-
azaGly-Gly-OtBu 42 as a colorless solid (263mg, 0.69mmol, 58%).
1H-NMR (400MHz, CDCl3): δ [ppm]=7.54 - 7.50 (m, 5H, CarH), 7.36 - 7.32 (m, 3H,
CarH), 7.25 - 7.23 (m, 2H, CarH), 4.04 (s, 2H, CH2), 1.51 (s, 9H, 3 xCH3).
13C-NMR (100MHz, CDCl3): δ [ppm]=169.5 (CtBu(O)), 155.6 (Curea), 149.1 (Cimin),
136.9 (Car), 131.8 (Car), 130.0 (Car), 129.9 (Car), 129.6 (Car), 128.5 (Car), 128.4 (Car),
127.3 (Car), 126.2 (Car), 115.7 (Car), 82.4 (CtBu), 42.6 (CH2), 28.2 (CH3).
ESI-MS: m/z =354.2 [M+H]+, 376.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C20H23N3O3H [M+H]+: 354.1812 found: 354.1812, calcd.
for C20H23N3O3Na [M+Na]+: 376.1632 found: 376.1630.
Alkylation of Benzhydrylidene Protected azaGly-Gly-OtBu (43)
The benzhydrylidene-azaGly-Gly-OtBu 42 (50.0mg, 0.13mmol, 1.00 eq) was dissolved in
THF (2mL) at 0 ◦C. Then, a 40% aq. TEAH solution (168.2µL, 0.26mmol, 2.00 eq)
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was added and the reaction solution was stirred for 30min at 0 ◦C. Subsequently, the
methoxy protected bromide nitroxide 40 (122mg, 0.39mmol, 3.00 eq) dissolved in THF
(0.5mL) was added slowly and the reaction solution was stirred at room temperature for
20 h. Afterwards, saturated aq. solution of citric acid (2mL) and saturated aq. NaCl
solution (2mL) were added. Then the organic layer was separated and the aqueous layer
was extracted by EtOAc (3 x 5mL). The combined organic layers were dried over MgSO4
and the solvent was removed under reduced pressure. Finally, the residue was purified
by flash column chromatography on SiO2 (DCM/MeOH, 95/5, v/v) to give the alkylated
benzhydrylidene-azaGly-Gly-OtBu 43 as a colorless solid (41.3mg, 68.9µmol, 53%).
1H-NMR (400MHz, CDCl3): δ [ppm]=7.52 - 7.51 (m, 2H, CarH), 7.47 - 7.44 (m, 6H,
CarH), 7.36 - 7.34 (m, 2H, CarH), 6.25 - 6.23 (m, 1H, CHurea), 4.00-3.98 (m, 4H, 2 xCH2),
3.67 (s, 3H, CH3), 1.45 (s, 9H, 3 xCtBuH3), 1.25 (s, 12H, 4 xCH3).
13C-NMR (100MHz, CDCl3): δ [ppm]=169.5, 168.6, 157.8, 138.4, 137.0, 134.6, 131.0,
130.4, 129.6, 128.7, 128.3, 126.3, 115.9, 81.9, 65.4, 43.8, 43.2, 28.2.
ESI-MS: m/z =599.2 [M+H]+, 621.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C30H39Br1N4O4H [M+H]+: 599.2227 found: 599.2231,
calcd. for C30H39Br1N4O4Na [M+Na]+: 621.2047 found: 621.2037.
Deprotection of Alkylated Benzhydrylidene Protected azaGly-Gly-OtBu (44)
The alkylated benzhydrylidene-azaGly-Gly-OtBu 43 (30mg, 50.0µmol, 1.00 eq) was added
to a precooled solution of DCM/TFA (v/v, 2/1, 1mL) at 0 ◦C and the reaction solution
was allowed to warm up to room temperature. Then, the reaction solution was stirred
at room temperature for 2 h. After removal of the solvent in a nitrogen stream, the
residue was dried in vacuo to yield the alkylated azaGly-Gly-OH dipeptide 44 (27.2mg,
50.0µmol, quantitative), that was used without further purification in the next step.
ESI-MS: m/z =543.2 [M+H]+, 565.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C26H31Br1N4O4H [M+H]+: 543.1601 found: 543.1596,
calcd. for C26H31Br1N4O4Na [M+Na]+: 565.1421 found: 565.1408.
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Coupling of the Alkylated Benzhydrylidene Protected azaGly-Gly-OtBu (45)
The alkylated azaGly-Gly-OH dipeptide 44 (21.8mg, 40µmol, 2.00 eq) was dissolved in
dry DMF (1mL) and HOAt (5.4mg, 40µmol, 2.00 eq) and HATU (14.4mg, 38µmol,
1.90 eq) were added followed by DIPEA (6.8µL, 40µmol, 2.00 eq) under an argon atmo-
sphere. The resulting reaction solution was stirred at room temperature for 5min and
was added to the swollen H-Gly-Gly-Lys(Boc)-Rink amide resin in DMF (1mL).The lat-
ter was previously prepared according to the standard operation procedure 7.3.2 on a
scale of 20µmol using a Rink amide MBHA resin with a loading capacity of 0.36mmol/g,
whereby the N-terminal Fmoc protection group was cleaved. The peptidyl resin was
agitated in the solution of the preactivated azadipeptide intermediate at room tempera-
ture for 19 h. Afterwards, the azapeptidyl resin was filtered and washed subsequently with
DMF (5 x 2mL), MeOH (5 x 2mL) and DCM (5 x 2mL). After drying the benzhydrylidene-
azapeptidyl resin 45 in vacuo, test-cleavage was performed by subjecting a small amount
of the peptidyl resin to a mixture of TFA/TIS/H2O (v/v/v, 95/2.5/2.5, 1mL) and the
cleavage was performed according to the standard operating procedure 7.3.3.
ESI-MS: m/z =784.3 [M+H]+, 806.3 [M+Na]+, 785.3 [M+2H]2+.
ESI-HRMS: m/z calcd. for C36H50Br1N9O6H [M+H]+: 784.3140 found: 784.3143,
calcd. for C36H50Br1N9O6Na [M+Na]+: 806.2960 found: 806.2948, C36H50Br1N9O6H2
[M+2H]2+: 392.6606 found: 392.6608.
Benzhydrylidene Deprotection of Alkylated azaGly-peptidyl Resin (46)
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A solution of 1.5M solution of NH2OH·HCl in pyridine (3mL) was added to the dried
benzhydrylidene-azapeptidyl resin 45 (20µmol, 1.00 eq) und the mixture was agitated
at 60 ◦C for 16 h. Then, the deprotected azapeptidyl resin was filtered and washed sub-
sequently with 10% DIPEA in DMF (5 x 2mL), DMF (5 x 2mL), MeOH (5 x 2mL) and
DCM (5 x 2mL). After drying the azapeptidyl resin 46 in vacuo, test-cleavage was per-
formed by subjecting a small amount of the peptidyl resin to a mixture of TFA/TIS/H2O
(v/v/v, 95/2.5/2.5, 1mL) and the cleavage was performed according to the standard op-
erating procedure 7.3.3.
ESI-MS: m/z =620.3 [M+H]+, 642.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C23H42Br1N9O6H [M+H]+: 620.2514 found: 620.2513,
calcd. for C23H42Br1N9O6Na [M+Na]+: 642.2334 found: 642.2325.
Coupling of Fmoc-Gly-OH to the Alkylated azaGly-peptidyl Resin (47)
Fmoc-Gly-OH (29.7mg, 100µmol, 5 eq) and DIC (7.7µL, 50.0µmol, 2.50 eq) were dis-
solved in dry DCM (3mL) 0 ◦C and the resulting solution was stirred for 30min at room
temperature. Then, the solvent was removed under reduced pressure and the residue was
redissolved in dry DMF (2mL). The solution of the pre-activated glycine amino acid was
transferred to the azapeptidyl resin 46, that was previously swollen in DMF (1mL) and
the mixture was agitated at room temperature for 16 h. Then, the elongated azapeptidyl
resin 47 was filtered and washed subsequently with DMF (5 x 2mL), MeOH (5 x 2mL) and
DCM (5 x 2mL). After drying the azapeptidyl resin 47 in vacuo, test-cleavage was per-
formed by subjecting a small amount of the peptidyl resin to a mixture of TFA/TIS/H2O
(v/v/v, 95/2.5/2.5, 1mL) and the cleavage was performed according to the standard op-
erating procedure 7.3.3.
ESI-MS: m/z =899.3 [M+H]+.
ESI-HRMS: m/z calcd. for C40H55Br1N10O9H [M+H]+: 899.3410 found: 899.3402.
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Elongation and Final Cleavage of the Alkylated azaGly-peptidyl Resin (51)
The Fmoc group of the azapeptidyl resin 47 (20µmol) was deprotected and the azapeptide
was subsequently elongated by coupling of the next amino acids according to the stan-
dard operating procedure 7.3.2 using the amino acids Fmoc-Gly-OH, Fmoc-Trp(Boc)-OH
and Fmoc-Lys(Boc)-OH. After the desired sequence was synthesized, the N-terminus was
acetylated. Then, the acetylated azapeptide was cleaved from the resin and isolated
following the standard operating procedure 7.3.3 using 2mL of the cleavage cocktail.
Finally, the freeze-dried crude peptide was purified by RP-HPLC on a C18 analytical
column using solvent B (0.1% TFA in MeCN) in A (0.1% TFA in di-demineralized water)
with a flow of 0.5mL per min.
HPLC (Gradient 5 to 50% B in 30min): tR=12.9min.
ESI-MS: m/z =383.8 [M+3H]3+, 575.3 [M+2H]2+, 1149.5 [M+H]+, 1169.5 [M+Na]+.
ESI-HRMS: m/z calcd. for C48H75Br1N16O12H [M+H]+: 1147.5007 found: 1147.4994,
calcd. for C48H75Br1N16O12H2 [M+2H]2+: 574.2540 found: 574.2549,
calcd. for C48H75Br1N16O12H3 [M+3H]3+: 383.1717 found: 383.1719,
calcd. for C48H75Br1N16O12Na [M+Na]+: 1169.4826 found: 1169.4814.
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7.6 Synthesis of Photolabile Protected TOPP Spin Label
Cbz-L-Hpg-OBn (54)[3,111]
To a solution of 4-hydroxyphenylglycine 52 (5.00 g, 28.4mmol, 1.00 eq) in an 10% aqueous
solution of Na2CO3 (70mL) a solution of CbzCl (4.41mL, 30.1mmol, 1.10 eq) in toluene
(5.0mL) and dioxane (55.0mL) was added dropwise at 0 ◦C. Then, the reaction mixture
was stirred at 0 ◦C for 30min and additional 1 h at room temperature. The organic solvent
was removed in vacuo and cold water (180mL) was added to the residual aqueous phase.
Subsequently, the aqueous phase was washed with EtOAc (3 x 50.0 mL) and was acidified
with 2M aq. HCl to pH 2. Then, the acid layer was extracted with EtOAc (3 x 70mL) and
the combined organci layers were washed with water (50mL), saturated aq. NaCl solu-
tion (50mL) and then dried over MgSO4. After the removal of the solvent under reduced
pressure and drying in vacuo, the Cbz-L-Hpg-OBn 53 was obtained as a colorless solid
(6.99 g, 23.2mmol, 69%) and used without further purification. The Cbz-L-Hpg-OBn 53
(8.00 g, 26.5mmol, 1.00 eq) and NaHCO3 (2.32 g, 27.6mmol, 1.00 eq) were dissolved in
dry DMF (130mL) and the mixture was cooled to 0 ◦C. Then, BnBr (5.51 g, 32.2mmol,
1.21 eq) was added dropwise and the reaction mixture was stirred at room temperature
for 20 h. Subsequently, H2O (210mL) was added to the mixture and the aqueous layer
was extracted with EtOAc (3 x 100mL). The combined organic layers were washed with
H2O (150mL), saturated aq. NaCl solution (3 x 100mL), dried over MgSO4 and the sol-
vent was removed in vacuo. Purifying the residue by flash column chromatography on
SiO2 (Pe/EtOAc, 70/30, v/v) gave the Cbz-L-Hpg-OBn 54 as a colourless solid (7.64 g,
19.5mmol, 75%).
1H-NMR (300MHz, DMCO-d6): δ [ppm]=9.51 (s, 1H, OH), 8.16 (d, 1H, 2JHH =7.8Hz,
NH), 7.35 - 7.32 (m, 10H, CHar), 6.72 - 6.70 (m, 2H, CHar), 5.19 (d, 3JHH =7.8Hz, 1H,
CαH), 5.12 (s, 2H, CH2), 5.06 (s, 2H, CH2).
13C-NMR (126MHz, DMSO-d6): δ [ppm]=171.0, 157.4, 155.9, 139.9, 135.8, 129.1, 128.5,
127.9, 127.7, 127.5, 126.2, 115.2, 66.0, 65.6, 57.5.
ESI-MS: m/z =392.2 [M+H]+, 414.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C23H21N1O5H [M+H]+: 414.1312 found: 414.1318, calcd.
for C23H21N1O5Na [M+Na]+: 409.1758 found: 409.1761.
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Cbz-L-Hpg(Tf)-OBn (55)[3,111]
Cbz-L-Hpg-OBn 54 (4.00 g, 9.85mmol, 1.00 eq) and pyridine (2.30mL, 29.6mmol, 3.00 eq)
were dissolved in dry DCM (35mL) and the reaction solution was cooled to 0 ◦C. After-
wards, Tf2O (2.41mL, 14.8mmol, 1.50 eq) was added dropwise and the reaction mixture
was stirred at 0 ◦C for 15min and was allowed to warm up to room temperature and stirred
for additional 40min. Then, saturated aq. NaHCO3 solution (60mL) was added and the
organic phase was separated. The aqueous phase was extracted with DCM (3 x 50mL) and
the combined organic phases were washed with saturated aq. NaCl solution (3 x 50mL),
dried over MgSO4 and the solvent was removed in vacuo. After the removal of the pyridine
by coevaporation with toluene, the residue was purified by flash column chromatography
on SiO2 (Pe/EtOAc, 70/30, v/v) to give the Cbz-L-Hpg(Tf)-OBn 55 as an yellowish solid
(5.63 g, 10.4mmol, 89%).
1H-NMR (300MHz, CDCl3): δ [ppm]=7.44 - 7.14 (m, 14H, CarH), 5.98 (d, 2JHH =5.7Hz,
1H, NH), 5.45 (d, 2JHH =6.3Hz, 1H, CαH), 5.16-5.01 (m, 4H, 2 xCH2).
13C-NMR (126MHz, CDCl3): δ [ppm]=169.9, 155.4, 149.5, 137.5, 136.0, 134.8, 129.2,
128.8, 128.5, 125.4, 121.9, 120.5, 117.3, 68.0, 67.5, 57.4.
ESI-MS: m/z =524.1 [M+H]+, 546.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C24H20N1O5SF3H [M+H]+: 524.0985 found: 524.0990,
calcd. for C24H20N1O5SF3Na [M+Na]+: 546.0805 found: 546.0809.
Bn2-L-Hpg(Tf)-OBn (56)[3,111]
Cbz-L-Hpg(Tf)-OBn 55 (8.00 g, 15.3mmol, 1.00 eq) and Me2S (33.6mL, 444mmol, 30.0 eq)
were dissolved in TFA (180mL) and the reaction solution was stirred at room tempera-
ture for 19 h. Then, TFA was removed by coevaporation with toluene to yield the crude
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deprotected intermediate, that was dissolved in DMSO (100mL). Afterwards, NaHCO3
(7.70 g, 91.9mmol, 6.00 eq) was added to the reaction solution and the reaction mixture
was stirred upon dropwise addition of BnBr (22.8mL, 275mmol, 18.0 eq) at room tem-
perature for 21 h. Then, H2O (500mL) and EtOAc (150mL) were added, the organic
layer was separated and the aqueous layer was extracted with EtOAc (3 x 100mL). The
combined organic layers were washed with H2O (200mL), saturated aq. NaCl solution
(3 x 200mL), dried over MgSO4 and the solvent was removed under reduced pressure.
Finally, the residue was purified by flash column chromatography on SiO2 (Pe/EtOAc,
80/20, v/v) to give the Bn2-L-Hpg(Tf)-OBn 56 as a colorless solid (3.26 g, 5.73mmol,
61%).
1H-NMR (300MHz, CDCl3): δ [ppm]=7.74 - 7.72 (m, 14H, CarH), 7.32 - 7.23 (m, 15H,
CarH), 7.20 - 7.18 (m, 2H, CarH), 5.27 (m, 2H, CH2), 4.63 (s, 1H, CHα), 3.71 - 3.70 (m,
4H, 2 xCH2).
ESI-MS: m/z =570.2 [M+H]+, 592.1 [M+Na]+.
ESI-HRMS: m/z calcd. for C30H26N1O5SF3H [M+H]+: 570.1557 found: 570.1555,
calcd. for C30H26N1O5SF3Na [M+Na]+: 592.1376 found: 592.1370.
Bn2-4-pinacolboryl-L-Phg-OBn (57)[3,111]
Bn2-L-Hpg(Tf)-OBn 56 (3.00 g, 5.27mmol, 1.00 eq), B2pin2 (1.60 g, 6.33mmol, 1.20 eq),
KOAc (1.56 g, 15.9mmol, 3.00 eq), PdCl2(dppf) (388mg, 530µmol, 0.10 eq) and dppf
(293mg, 530µmol, 0.10 eq) were dissolved in degassed dioxane (60mL) under an argon
atmosphere and the reaction mixture was stirred at 80 ◦C for 6 h. Then, EtOAc (250mL)
was added to the mixture and the organic phase was washed with saturated aq. NaCl solu-
tion (3 x 100 mL) and dried over MgSO4. After removal of the solvent in vacuo, the crude
product was purified by flash column chromatography on SiO2 (Pe/EtOAc, 98/2, v/v)
to give the Bn2-4-pinacolboryl-L-Phg-OBn 57 as a light yellowish oil (2.57 g, 4.69mmol,
84%).
1H-NMR (400MHz, CDCl3): δ [ppm]=7.73 (d, 2H, 3JHH =6.0Hz, 2 xCarH ), 7.32 -
7.18 (m, 17H, CarH), 5.26 (d, 2JHH =12.4Hz, 1H, CH2), 5.14 (d, 2JHH =12.4Hz, 1H,
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CH2), 4.62 (s, 1H, CαH), 3.70 (s, 4H, 2 xCH2), 1.40 (s, 12H, 4 xCH3).
13C-NMR (126MHz, CDCl3): δ [ppm]=171.8, 139.7, 139.3, 135.8, 134.7, 128.8, 128.5,
128.4, 128.3, 128.2, 128.2, 127.0, 83.8, 66.2, 65.8, 54.2, 24.9, 24.8, 24.7.
ESI-MS: m/z =548.3 [M+H]+, 570.3 [M+Na]+.
ESI-HRMS: m/z calcd. for C35H38BNO4H [M+H]+: 548.2973 found: 548.2979, calcd.
for C35H38BNO4Na [M+Na]+: 570.2792 found: 570.2790.
Bn2-4-dihydroxyboron-L-Phg-OBn (58)[3,111]
Bn2-4-pinacolboryl-L-Phg-OBn (57) (3.00 g, 5.48mmol, 1.00 eq) was dissolved in
acetone/H2O (3/2.5, v/v, 550mL), followed by addition of NaIO4 (3.63 g, 17.0mmol,
3.10 eq) and NH4OAc (1.27 g, 16.5mmol, 3.00 eq). Then, the reaction mixture was stirred
at room temperature for 54 h. After removal of the organic solvent under reduced pres-
sure, the aqueous layer was extracted with Et2O (3 x 100mL) and the combined organic
layers were washed with saturated aq. NaCl solution (3 x 50mL) and dried over MgSO4.
Finally, the removal of the organic solvent in vacuo gave the Bn2-4-dihydroxyboron-L-
Phg-OBn 58 as a colorless solid (2.40 g, 5.17mmol, 82%).
1H-NMR (400MHz, CDCl3): δ [ppm]=8.17 (d, 2H, 3JHH =8.0Hz, CarH ), 7.47 (d, 2H,
3JHH =8.0Hz, CarH ), 7.38 - 7.22 (m, 15H, CarH) 5.36 (d, 2JHH =12.0Hz, 1H, CH2),
5.23 (d, 2JHH =12.0Hz, 1H, CH2), 4.74 (s, 1H, CHα), 4.65 (s, 4H, 2 xCH2).
13C-NMR (126MHz, CDCl3): δ [ppm]= 171.7, 141.4, 139.3, 135.7, 135.6, 133.5, 129.6,
128.8, 128.7, 128.6, 128.5, 128.4, 128.4, 128.4, 128.3, 128.3, 127.1, 127.0, 66.3, 65.9, 65.7,
54.3, 54.2.
ESI-MS: m/z =466.2 [M+H]+, 480.2 [M+CH2]+, 494.3 [M+2CH2]+.
ESI-HRMS: m/z calcd. for C29H28BN1O4H [M+H]+: 466.2189 found: 466.2187, calcd.
for C29H28BN1O4CH2 [M+CH2]+: 480.2346 found: 480.2350, calcd. for C29H28BN1O4C2H2
[M+2CH2]+: 494.2503 found: 494.2497.
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2,2’-Imino-bis(2-methylpropionitrile) (60)
2-Amino-2-methylpropionitrile hydrochloride (10 g, 82.9mmol, 1.00 eq) was dissolved in
EtOAC and subsequently an 10% aq. solution of NaHCO3 was added until the pH=7
was reached. Then, the organic layer was separated and the aqueous layer was extracted
with EtOAc (3 x 20mL). The combined organic layers were dried over MgSO4 and the
solvent was removed in vacuo. Afterwards, the residue was kept for 5 d at 30-50mbar at
room temperature to yield the 2,2’-Imino-bis(2-methylpropionitrile) 60 as a beige solid
(1.88 g, 12.4mmol, 30%).
1H-NMR (300MHz, DMSO-d6): δ [ppm]=1.65 (s, 12H, 4 xCH3).
13C-NMR (126MHz, DMSO-d6): δ [ppm]=123.5, 49.2, 29.1.
3,3,5,5-Tetramethylpiperazine-2,6-dione (61)[3,111]
To precooled 68% H2SO4 (7.0 mL) 2,2’-imino-bis(2-methylpropionitrile) 60 (1.00 g, 6.60mmol,
1.00 eq) was added in portions over 2 h at 5 ◦C. Then, the solution was stirred at room
temperature for 4 d, for 1 h at 100 ◦C and for additional 16 h at room temperature. After
the addition of ice (100 g), a 10M aq. NaOH solution was added slowly until the aqueous
phase reached the pH=7. Then, the solvent was removed under reduced pressure and the
residue was suspended in MeOH (5mL). The precipitate was filtered off and the filtrate
was concentrated under reduced pressure. After washing the residue with H2O and Et2O
the 3,3,5,5-Tetramethylpiperazine-2,6-dione 61 was obtained after drying in vacuo as a
colorless solid (269mg, 1.58mmol, 24%).
1H-NMR (300MHz, DMSO-d6): δ [ppm]=10.65 (s (br.), 1H, NHimid), 2.82 (s (br.),
1H, NHamin), 1.25 (s, 12H, 4 xCH3).
13C-NMR (126MHz, DMSO-d6): δ [ppm]=178.2, 55.0, 27.9.
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Bn2-4-(3,3,5,5-tetramethyl-2,6-dioxopiperazine-1-yl)-L-Phg-OBn (63)[3,111]
Bn2-4-dihydroxyboron-L-Phg-OBn 58 (2.00 g, 4.30mmol, 1.00 eq), piperazine-2,6-dion 61
(730mg, 4.30mmol, 1.00 eq), Cu(OAc)2 (781mg, 4.30mmol, 1.00 eq), Et3N (0.83mL,
6.07mmol, 1.40 eq) and 4Å molecular sieve pellets (2 g) were subjected to DMSO (150mL)
and the reaction mixture was stirred at room temperature under an oxygen atmosphere
of 3 bar for 3 d. Then, the reaction mixture was filtered through a pad of celite and the
filtrate was portioned between EtOAc (150mL) and H2O (150mL). After the mixture was
acidified by addition of 1M aq. HCl, the organic phase was separated. Then, the aqueous
phase was extracted with EtOAc (3 x 100mL), the combined organic phases were washed
with saturated aq. NaCl solution (3 x 100 mL) and dried over MgSO4. After removal of
the solvent under reduced pressure, the residue was purified by flash column chromatog-
raphy on SiO2 (Pe/EtOAc, 2/1 to 1/1, v/v) to yield the Bn2-4-(3,3,5,5-tetramethyl-2,6-
dioxopiperazine-1-yl)-L-Phg-OBn 63 as a yellowish solid (947mg, 3.27mmol, 76%).
1H-NMR (400MHz, CDCl3): δ [ppm]=7.42 (d, 2H, 3JHH =8.4Hz, CarH ), 7.35 - 7.19
(m, 15H, CarH), 7.02 (d, 2H, 3JHH =8.4Hz, CarH ), 5.32 (d, 2JHH =12.4Hz, 1H, CH2),
5.15 (d, 2JHH =12.4Hz, 1H, CH2), 4.65 (s, 1H, CHα), 3.78 (d, 2JHH =14.0Hz, 2H,
CH2), 3.69 (d, 2JHH =14.0Hz, 2H, CH2), 1.50 (s, 12H, 4 xCH3).
13C-NMR (126MHz, CDCl3): δ [ppm]= 176.6, 171.6, 139.3, 135.9, 129.6, 128.9, 128.7,
128.5, 128.4, 128.3, 127.2, 66.5, 65.5, 56.2, 54.3, 28.6.
ESI-MS: m/z =590.3 [M+H].
ESI-HRMS: m/z calcd. for C37H39N3O4H [M+H]+: 590.3013 found: 590.2991.
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Fmoc-4-(3,3,5,5-tetramethyl-2,6-dioxopiperazine-1-yl)-L-Phg-OH (64)[3,111]
To a solution of Bn2-4-(3,3,5,5-tetramethyl-2,6-dioxopiperazine-1-yl)-L-Phg-OBn 63
(500mg, 850µmol, 1.00 eq) in MeOH (20mL) and DCM (3mL) the 50% H2O containing
Pd(OH)2/C (100mg, 71.2µmol, 0.08 eq) was added and the solution was purged with
hydrogen. Then, the reaction mixture was stirred at room temperature under a hydrogen
atmosphere for 20 h. Afterwards, the suspension was filtered through a celite pad and the
filtrate was concentrated under reduced pressure to give the unprotected intermediate.
Then, the intermediate was redissolved in DMF (6mL) and NaHCO3 (143mg, 1.70mmol,
2.00 eq) and Fmoc-OSu (287mg, 850µmol, 1.00 eq) were added. The reaction mixture
was stirred at room temperature for 24 h. Subsequently, H2O (25mL) was added and
the aqueous phase was acidified with 2M aq. HCl to pH2. After extraction of the or-
ganic phase with EtOAc (5 x 200 mL), the organic phases were combined, washed with
saturated aq. NaCl solution (200mL) and dried over MgSO4. Then, the solvent was
removed in vacuo and the residue was purified by flash column chromatography on SiO2
(DCM/MeOH containing 0.1% AcOH, 98/2 to 90/10, v/v) to yield the Fmoc-4-(3,3,5,5-
tetramethyl-2,6-dioxopiperazine-1-yl)-L-Phg-OH 64 as a colorless solid (271mg, 532mol,
59%).
1H-NMR (400MHz, DMSO-d6): δ [ppm]=8.27 (d, 1H, 2JHH =8.0Hz, NamidH ), 7.89
(d, 2H, 3JHH =7.6Hz, CarH ), 7.78 - 7.75 (m, 2H, CarH), 7.52 - 7.31 (m, 6H, CarH), 7.11
(d, 2H, 3JHH =8.4Hz, CarH ), 5.22 (d, 2JHH =8.0Hz, 1H, CαH), 4.30 - 4.23 (m, 3H,
CH1, CH2), 1.39 (s, 12H, 4 xCH3).
ESI-MS: m/z =542.2 [M+H]+, 564.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C31H31N3O6H [M+H]+: 542.2286 found: 542.2264, calcd.
for C31H31N3O6Na [M+Na]+: 564.2105 found: 564.2109.
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Fmoc-4-(3,3,5,5-tetramethyl-2,6-dioxo-4-oxylpiperazine-1-yl)-L-Phg-OH (65)[3,111]
A solution of the amine 64 (400mg, 740µmol, 1.00 eq) in DCM (98.0 mL) was cooled to
0 ◦C and upon the addition of a solution of m-CPBA (70%, 364mg, 1.48mmol, 2.00 eq)
in DCM (2.0mL), the reaction mixture was stirred at 0 ◦C for 15min and after warm-
ing up to room temperature for additional 5 h. Then, the solvent was removed in vacuo
and the residue was purified by flash column chromatography on SiO2 (DCM/MeOH
containing 0.1% AcOH, 98/2 to 94/6, v/v) to yield the Fmoc-4-(3,3,5,5-tetramethyl-2,6-
dioxo-4-oxylpiperazine-1-yl)-L-Phg-OH 65 as an orange solid (317mg, 571µmol, 77%).
ESI-MS: m/z =557.2 [M+H]+, 574.2 [M+NH4]+, 579.2 [M+Na]+.
ESI-HRMS: m/z calcd. for C31H30N3O7H [M+H]+: 557.2157 found: 557.2131, calcd.
for C31H30N3O7NH4 [M+NH4]+: 574.2422 found: 574.2403, calcd. for C31H30N3O7Na
[M+Na]+: 579.1976 found: 579.1960.
2-Nitrobenzyl Protected α-TOPP Spin Label (66)[97]
To a solution of the nitroxide 65 (500mg, 898µmol, 1.00 eq) in THF (5mL) was added
20w% Pd/C (100mg) and the reaction mixture was purged with hydrogen and subse-
quently stirred under a hydrogen atmosphere at room temperature for 2 h. Then, the
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reaction solution was purged with argon and Et3N (0.37mL, 2.69mmol, 3.00 eq) and 2-
nitrobenzyl bromide (291mg, 1.35mmol, 1.50 eq) were added. The mixture was stirred at
room temperature for 9 h. Afterwards, the mixture was filtered through a pad of celite and
the solvent was removed under reduced pressure. The residue was purified by flash column
chromatography on SiO2 (DCM/MeOH, 98/2 to 90/10, v/v) to yield the 2-nitrobenzyl
protected nitroxide as a colorless solid (131mg, 189µmol, 21%).
ESI-MS: m/z =715.2 [M+Na]+, 710.3 [M+NH4]+.
ESI-HRMS: m/z calcd. for C38H36N4O9Na [M+Na]+: 715.2374 found: 715.2358, calcd.
for C38H36N4O9NH4 [M+NH4]+: 710.2821 found: 710.2792.
DMNB Protected α-TOPP Spin Label (67)[97]
The DMNB protected nitroxide 67 was performed applying the same procedure as de-
scribed for the 2-nitrobenzyl protected nitroxide 66, using the nitroxide 65 (100mg,
180µmol, 1.00 eq), 20w% Pd/C (20mg), Et3N (0.07mL, 0.54mmol, 3.00 eq) and 4,5-
dimethoxy-2-nitrobenzyl bromide (74.6mg, 0.27mmol, 1.50 eq). The desired product 67
was obtained as a colorless solid (24.5mg, 32.6µmol, 24%).
ESI-MS: m/z =753.3 [M+H]+, 775.3 [M+H]+, 770.3 [M+NH4]+.
ESI-HRMS: m/z calcd. for C40H40N4O11H [M+H]+: 753.2766 found: 753.2755, calcd.
for C40H40N4O11NH4 [M+NH4]+: 770.3032 found: 770.3019, calcd. for C40H40N4O11Na
[M+Na]+: 775.2586 found: 775.2577.
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8 Appendix
Figure 57: CD measurement of the azapeptide 51 in MeOH (50µM) in the wavelength range from 260
to 190 nm.
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